Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS1M
Performance in the last:
Follow this Portfolio
1D -1.5 %
1W -7.8 %
2W 4.5 %
1M 18.5 %
3M 10.3 %
6M -2.7 %
9M -81.7 %
1Y -78.9 %
Alpha
-101.6%
Beta
0.76
sharpe-R
-0.9
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.45
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-11-21 08:30:36
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -86.36%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 12.16% 17.95%
HCSG Healthcare Services Group, Inc. Buy 10.47% 4.02%
NEOG Neogen Corporation Buy 12.17% 3.91%
ITGR Integer Holdings Corporation Buy 28.1% -2.48%
CUTR Cutera, Inc. Sell -2.17% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.29% 4.34%
TNDM Tandem Diabetes Care, Inc. Sell -6.95% 1.47%
KIDS OrthoPediatrics Corp. Sell -7% 0.86%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.79% 17.98%
The percentage of cash held in the portfolio is: 66.29%
** The description of each asset is available Here

The latest 5 Compositions change

2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 12.02% 17.66%
HCSG Healthcare Services Group, Inc. Buy 10.36% 3.74%
NEOG Neogen Corporation Buy 12.22% 5.23%
ITGR Integer Holdings Corporation Buy 27.9% -2.37%
CUTR Cutera, Inc. Sell -2.15% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.15% 5.36%
TNDM Tandem Diabetes Care, Inc. Sell -6.37% 8.92%
KIDS OrthoPediatrics Corp. Sell -6.62% 5.44%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.95% 14.91%
The percentage of cash held in the portfolio is: 65.74%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -10.08%
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 11.94% 17.18%
HCSG Healthcare Services Group, Inc. Buy 10.49% 5.39%
NEOG Neogen Corporation Buy 11.79% 1.81%
MGNX MacroGenics, Inc. Buy 9.2% -7.75%
ITGR Integer Holdings Corporation Buy 27.75% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.96% -5.24%
CUTR Cutera, Inc. Sell -2.29% 42.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.29% 3.21%
TNDM Tandem Diabetes Care, Inc. Sell -6.23% 10.65%
KIDS OrthoPediatrics Corp. Sell -6.22% 10.85%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.01% 13.91%
The percentage of cash held in the portfolio is: 42.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
VREX Sell All 13.22%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 10.67% 12.89%
CDMO Avid Bioservices, Inc. Buy 11.51% 15.15%
HCSG Healthcare Services Group, Inc. Buy 10.64% 8.95%
NEOG Neogen Corporation Buy 11.6% 2.09%
MGNX MacroGenics, Inc. Buy 9.63% -1.55%
ITGR Integer Holdings Corporation Buy 27.55% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.89% -3.91%
RGEN Repligen Corporation Buy 10.96% -5.34%
CUTR Cutera, Inc. Sell -2.31% 41.07%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.22% 2.23%
TNDM Tandem Diabetes Care, Inc. Sell -6.39% 6.57%
KIDS OrthoPediatrics Corp. Sell -6.04% 11.78%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.26% 8.49%
The percentage of cash held in the portfolio is: 21.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 26.23%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 10.56% 15.04%
NUTX Nutex Health Inc. Buy 12.35% 31.39%
CDMO Avid Bioservices, Inc. Buy 11.43% 17.76%
HCSG Healthcare Services Group, Inc. Buy 10.56% 11.32%
NEOG Neogen Corporation Buy 11.68% 5.86%
MGNX MacroGenics, Inc. Buy 9.26% -2.58%
ITGR Integer Holdings Corporation Buy 27.3% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.91% -0.89%
ALT Altimmune, Inc. Buy 8.22% 0.32%
RGEN Repligen Corporation Buy 11.25% 0%
CUTR Cutera, Inc. Sell -2.45% 35.71%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.08% 1.32%
TNDM Tandem Diabetes Care, Inc. Sell -6.44% 3.04%
KIDS OrthoPediatrics Corp. Sell -6.27% 5.68%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.26% 5.78%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
ARWR Sell All 11.73%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.91% 11.11%
VREX Varex Imaging Corporation Buy 10.63% 18.26%
NUTX Nutex Health Inc. Buy 13.93% 51.33%
CDMO Avid Bioservices, Inc. Buy 11.22% 18.05%
HCSG Healthcare Services Group, Inc. Buy 10.55% 13.61%
NEOG Neogen Corporation Buy 11.56% 6.97%
MGNX MacroGenics, Inc. Buy 9.86% 5.94%
ITGR Integer Holdings Corporation Buy 26.6% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.57% -1.24%
ALT Altimmune, Inc. Buy 8.02% 0%
CUTR Cutera, Inc. Sell -2.6% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.27% -3.51%
TNDM Tandem Diabetes Care, Inc. Sell -6.61% -1.63%
KIDS OrthoPediatrics Corp. Sell -6.08% 6.53%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.27% 3.7%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
IOVA Sell All -12.15%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.24% 13.48%
VREX Varex Imaging Corporation Buy 10.94% 20.74%
NUTX Nutex Health Inc. Buy 10.44% 12.45%
CDMO Avid Bioservices, Inc. Buy 11.34% 18.24%
IOVA Iovance Biotherapeutics, Inc. Buy 8.92% -3.45%
HCSG Healthcare Services Group, Inc. Buy 10.44% 11.51%
NEOG Neogen Corporation Buy 12.46% 14.37%
MGNX MacroGenics, Inc. Buy 10.65% 13.44%
ITGR Integer Holdings Corporation Buy 27.35% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.86% 0%
CUTR Cutera, Inc. Sell -2.62% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.47% -5.38%
TNDM Tandem Diabetes Care, Inc. Sell -6.73% -2.52%
KIDS OrthoPediatrics Corp. Sell -6.38% 2.88%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.45% 1.81%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
Asset Action Perf %
VCEL Sell All 34.9%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 13.31% 28.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.29% 13.07%
VREX Varex Imaging Corporation Buy 10.74% 17.52%
NUTX Nutex Health Inc. Buy 11.9% 27.16%
CDMO Avid Bioservices, Inc. Buy 11.44% 18.34%
IOVA Iovance Biotherapeutics, Inc. Buy 8.94% -3.99%
HCSG Healthcare Services Group, Inc. Buy 10.24% 8.4%
NEOG Neogen Corporation Buy 12.44% 13.18%
MGNX MacroGenics, Inc. Buy 10.64% 12.4%
ITGR Integer Holdings Corporation Buy 27.04% 0%
CUTR Cutera, Inc. Sell -2.65% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.49% -4.82%
TNDM Tandem Diabetes Care, Inc. Sell -6.62% 0%
KIDS OrthoPediatrics Corp. Sell -6.62% 0%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.62% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TNDM
  • KIDS
  • ENTA
  • ITGR
Assets Removed
Asset Action Perf %
EVH Buy All 42.39%
ARDX Sell All -16.06%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 12.46% 5.63%
VCEL Vericel Corporation Buy 12.47% 18.86%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.16% 10.49%
VREX Varex Imaging Corporation Buy 10.9% 17.93%
NUTX Nutex Health Inc. Buy 11.02% 16.4%
CDMO Avid Bioservices, Inc. Buy 11.55% 18.15%
IOVA Iovance Biotherapeutics, Inc. Buy 10.48% 11.33%
HCSG Healthcare Services Group, Inc. Buy 10.25% 7.31%
NEOG Neogen Corporation Buy 12.23% 10.04%
MGNX MacroGenics, Inc. Buy 11.03% 15.25%
EVH Evolent Health, Inc. Sell -4.82% -5.95%
CUTR Cutera, Inc. Sell -3.5% 8.93%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.23% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMPH
Assets Removed
None
Assets Rebalanced
Asset Action Weight
VCEL Buy 0.56%
NEOG Buy 0.89%
ARDX Buy 1.17%
ARWR Buy 1.45%
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 10.71% 7.45%
VCEL Vericel Corporation Buy 10.71% 14.14%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.02% 10.23%
VREX Varex Imaging Corporation Buy 11.41% 19.42%
NUTX Nutex Health Inc. Buy 10.71% 9.47%
CDMO Avid Bioservices, Inc. Buy 10.71% 5.98%
HCSG Healthcare Services Group, Inc. Buy 10.71% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 10.71% 10.06%
NEOG Neogen Corporation Buy 10.71% 8.93%
MGNX MacroGenics, Inc. Buy 10.71% 8.27%
EVH Evolent Health, Inc. Sell -5.03% -6.81%
CUTR Cutera, Inc. Sell -4.11% -3.57%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All -11.47%
NVCR Buy All -19.24%
Assets Rebalanced
Asset Action Weight
ARWR Sell -1.57%
VCEL Sell -1.29%
NUTX Sell -2.27%
ARDX Sell -2.9%
CDMO Sell -2.98%
HCSG Sell -6.89%
IOVA Sell -7.14%
NEOG Buy 3.21%
MGNX Buy 5.79%
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 13.48% -2.48%
VCEL Vericel Corporation Buy 12.09% 5.42%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.88% 3.62%
VREX Varex Imaging Corporation Buy 11.41% 9.5%
NUTX Nutex Health Inc. Buy 12.01% -7.17%
CDMO Avid Bioservices, Inc. Buy 14.07% -0.19%
HCSG Healthcare Services Group, Inc. Buy 18.05% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 18.35% 3.72%
NEOG Neogen Corporation Buy 7.56% 0.63%
MGNX MacroGenics, Inc. Buy 4.75% -4.39%
EVH Evolent Health, Inc. Sell -5.17% -0.73%
SMTI Sanara MedTech Inc. Sell -7.8% -6.02%
NVCR NovoCure Limited Sell -8.37% -9.29%
CUTR Cutera, Inc. Sell -4.33% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CUTR
Assets Removed
None
Assets Rebalanced
Asset Action Weight
ARDX Buy 1.18%
VREX Buy 2.03%
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 11.62% 0.83%
VCEL Vericel Corporation Buy 12.04% 4.51%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.6% 0.67%
VREX Varex Imaging Corporation Buy 9.39% 9.09%
NUTX Nutex Health Inc. Buy 11.84% -8.94%
CDMO Avid Bioservices, Inc. Buy 14.04% -0.87%
HCSG Healthcare Services Group, Inc. Buy 18.1% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 18.04% 1.45%
NEOG Neogen Corporation Buy 7.6% 0.7%
MGNX MacroGenics, Inc. Buy 4.99% 0%
EVH Evolent Health, Inc. Sell -5.22% -1.16%
SMTI Sanara MedTech Inc. Sell -7.85% -6.21%
NVCR NovoCure Limited Sell -8.2% -6.59%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
CUTR Buy All 21.33%
FATE Buy All 24.3%
IRWD Sell All -1.64%
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.27% -7.28%
ARDX Ardelyx, Inc. Buy 11.52% -2.81%
VCEL Vericel Corporation Buy 12.4% 4.63%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.77% -0.67%
VREX Varex Imaging Corporation Buy 9.6% 8.51%
NUTX Nutex Health Inc. Buy 12.01% -10.19%
CDMO Avid Bioservices, Inc. Buy 14% -3.86%
HCSG Healthcare Services Group, Inc. Buy 18.31% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 17.3% -5.35%
NEOG Neogen Corporation Buy 7.73% -0.42%
CUTR Cutera, Inc. Sell -4.51% 22.67%
FATE Fate Therapeutics, Inc. Sell -4.3% 26.17%
EVH Evolent Health, Inc. Sell -5.34% -0.69%
SMTI Sanara MedTech Inc. Sell -7.95% -4.6%
NVCR NovoCure Limited Sell -7.91% 0%
The percentage of cash held in the portfolio is: 2.1%
New Assets Added
  • NVCR
Assets Removed
Asset Action Perf %
ORMP Buy All 0.42%
Assets Rebalanced
Asset Action Weight
CDMO Buy 0.85%
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.96% -0.23%
ARDX Ardelyx, Inc. Buy 11.52% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.95% 3.2%
VCEL Vericel Corporation Buy 12.61% 8.89%
VREX Varex Imaging Corporation Buy 9.51% 10%
NUTX Nutex Health Inc. Buy 11.63% -10.96%
CDMO Avid Bioservices, Inc. Buy 11.94% -1.74%
HCSG Healthcare Services Group, Inc. Buy 17.98% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 17.51% -1.99%
NEOG Neogen Corporation Buy 7.59% 0%
CUTR Cutera, Inc. Sell -5.09% 10.67%
FATE Fate Therapeutics, Inc. Sell -4.83% 15.26%
ORMP Oramed Pharmaceuticals Inc. Sell -5.46% 4.18%
EVH Evolent Health, Inc. Sell -5.2% -0.34%
SMTI Sanara MedTech Inc. Sell -7.63% -2.69%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.55% -2.58%
ARDX Ardelyx, Inc. Buy 11.25% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12% 4.24%
VCEL Vericel Corporation Buy 12.49% 8.48%
VREX Varex Imaging Corporation Buy 9.34% 8.68%
NKTR Nektar Therapeutics Buy 8.06% -6.21%
NUTX Nutex Health Inc. Buy 12.56% -3.3%
CDMO Avid Bioservices, Inc. Buy 11.77% -2.51%
HCSG Healthcare Services Group, Inc. Buy 17.76% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 17.76% 0%
CUTR Cutera, Inc. Sell -5.06% 10.67%
FATE Fate Therapeutics, Inc. Sell -5.06% 10.59%
ORMP Oramed Pharmaceuticals Inc. Sell -5.5% 2.93%
EVH Evolent Health, Inc. Sell -5.24% -1.81%
SMTI Sanara MedTech Inc. Sell -7.69% -4.15%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.98% -7.04%
ARDX Ardelyx, Inc. Buy 11.9% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.93% 3.82%
VCEL Vericel Corporation Buy 12.94% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 19.24% 54.64%
VREX Varex Imaging Corporation Buy 9.92% 6.69%
NKTR Nektar Therapeutics Buy 8.47% -8.97%
NUTX Nutex Health Inc. Buy 13.75% -2.14%
CDMO Avid Bioservices, Inc. Buy 12.61% -3.47%
CUTR Cutera, Inc. Sell -5.23% 14.67%
FATE Fate Therapeutics, Inc. Sell -5.06% 17.45%
ORMP Oramed Pharmaceuticals Inc. Sell -6.07% 0.84%
EVH Evolent Health, Inc. Sell -5.77% -3.58%
SMTI Sanara MedTech Inc. Sell -8.02% -0.48%
The percentage of cash held in the portfolio is: 14.41%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.98% -6.57%
ORGO Organogenesis Holdings Inc. Buy 11.62% -6.82%
ARDX Ardelyx, Inc. Buy 12.01% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.74% 2.94%
VCEL Vericel Corporation Buy 12.61% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 19.01% 53.61%
VREX Varex Imaging Corporation Buy 9.8% 5.95%
NKTR Nektar Therapeutics Buy 8.61% -6.9%
NUTX Nutex Health Inc. Buy 13.83% -0.97%
CDMO Avid Bioservices, Inc. Buy 12.8% -1.45%
CUTR Cutera, Inc. Sell -5.28% 13.33%
FATE Fate Therapeutics, Inc. Sell -5.33% 12.46%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% 1.26%
EVH Evolent Health, Inc. Sell -5.44% 1.81%
SMTI Sanara MedTech Inc. Sell -7.94% 0%
The percentage of cash held in the portfolio is: 2.99%
New Assets Added
  • SMTI
Assets Removed
None
Assets Rebalanced
Asset Action Weight
NUTX Buy 1.12%
IRWD Buy 1.79%
CDMO Buy 1.83%
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.06% -6.57%
ORGO Organogenesis Holdings Inc. Buy 11.76% -6.17%
ARDX Ardelyx, Inc. Buy 11.49% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.8% 2.89%
VCEL Vericel Corporation Buy 12.49% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 19.74% 58.76%
VREX Varex Imaging Corporation Buy 9.79% 5.37%
NKTR Nektar Therapeutics Buy 9.03% -2.76%
NUTX Nutex Health Inc. Buy 11.28% -4.88%
CDMO Avid Bioservices, Inc. Buy 11.19% 0%
CUTR Cutera, Inc. Sell -5.38% 12%
FATE Fate Therapeutics, Inc. Sell -5.77% 5.61%
ORMP Oramed Pharmaceuticals Inc. Sell -6.09% 0.42%
EVH Evolent Health, Inc. Sell -5.38% 3.41%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.55% -4.23%
ORGO Organogenesis Holdings Inc. Buy 12.84% 0.65%
ARDX Ardelyx, Inc. Buy 12.12% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.33% 5.27%
VCEL Vericel Corporation Buy 12.58% -0.62%
CDXS Codexis, Inc. Buy 12.32% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 15.79% 24.74%
VREX Varex Imaging Corporation Buy 9.8% 3.64%
NKTR Nektar Therapeutics Buy 9.39% -0.69%
NUTX Nutex Health Inc. Buy 12.07% 0%
CUTR Cutera, Inc. Sell -5.8% 6.8%
FATE Fate Therapeutics, Inc. Sell -6.19% 0.62%
ORMP Oramed Pharmaceuticals Inc. Sell -6.18% 0.84%
EVH Evolent Health, Inc. Sell -5.61% 0.99%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
Assets Removed
Asset Action Perf %
IRTC Buy All -20.54%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.16% -1.64%
ORGO Organogenesis Holdings Inc. Buy 13.22% 0.97%
ARDX Ardelyx, Inc. Buy 12.65% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.75% 5.84%
VCEL Vericel Corporation Buy 12.71% -2.16%
CDXS Codexis, Inc. Buy 12.6% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 12.18% -6.19%
VREX Varex Imaging Corporation Buy 10.1% 4.13%
NKTR Nektar Therapeutics Buy 9.3% -4.14%
CUTR Cutera, Inc. Sell -5.96% 6.67%
FATE Fate Therapeutics, Inc. Sell -6.27% 1.87%
ORMP Oramed Pharmaceuticals Inc. Sell -6.28% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.67% 0.97%
EVH Evolent Health, Inc. Sell -5.81% 0%
The percentage of cash held in the portfolio is: 21.34%
New Assets Added
  • EVH
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.64% 4.23%
ORGO Organogenesis Holdings Inc. Buy 12.79% -0.32%
ARDX Ardelyx, Inc. Buy 12.3% -3.48%
BKD Brookdale Senior Living Inc. Buy 13.92% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.71% 7.64%
VCEL Vericel Corporation Buy 12.31% -3.37%
CDXS Codexis, Inc. Buy 12.66% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 12.34% -3.09%
VREX Varex Imaging Corporation Buy 9.51% 0%
NKTR Nektar Therapeutics Buy 9.51% 0%
CUTR Cutera, Inc. Sell -5.51% 12%
FATE Fate Therapeutics, Inc. Sell -6.28% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.29% -0.42%
IRTC iRhythm Technologies, Inc. Sell -5.6% 0.35%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.36% 3.05%
ORGO Organogenesis Holdings Inc. Buy 13.19% 3.9%
ARDX Ardelyx, Inc. Buy 12.46% -1.16%
BKD Brookdale Senior Living Inc. Buy 12.64% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.94% 2.69%
VCEL Vericel Corporation Buy 12.56% -0.33%
RDNT RadNet, Inc. Buy 12.63% 0.2%
CDXS Codexis, Inc. Buy 12.59% 0%
SGMO Sangamo Therapeutics, Inc. Buy 12.59% 0%
CUTR Cutera, Inc. Sell -5.7% 8%
FATE Fate Therapeutics, Inc. Sell -5.89% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -6.09% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.33% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -5.55% 0.18%
The percentage of cash held in the portfolio is: 14.59%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.21% 0.7%
ORGO Organogenesis Holdings Inc. Buy 12.87% 0.32%
ARDX Ardelyx, Inc. Buy 12.63% -0.83%
BKD Brookdale Senior Living Inc. Buy 12.73% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.73% 0%
VCEL Vericel Corporation Buy 12.73% 0%
RDNT RadNet, Inc. Buy 12.73% 0%
CUTR Cutera, Inc. Sell -5.93% 5.33%
FATE Fate Therapeutics, Inc. Sell -5.95% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -6.24% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.19% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -5.54% 1.35%
The percentage of cash held in the portfolio is: 40.2%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.2% 0%
ORGO Organogenesis Holdings Inc. Buy 12.87% -0.32%
ARDX Ardelyx, Inc. Buy 12.81% 0%
CUTR Cutera, Inc. Sell -6.39% -1.33%
FATE Fate Therapeutics, Inc. Sell -6.07% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -6.28% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.14% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -5.71% -1.12%
The percentage of cash held in the portfolio is: 91.7%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.01% -1.17%
ORGO Organogenesis Holdings Inc. Buy 12.61% -1.95%
CUTR Cutera, Inc. Sell -6.11% 2.67%
FATE Fate Therapeutics, Inc. Sell -5.75% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -6.3% -0.42%
IRTC iRhythm Technologies, Inc. Sell -5.15% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -5.4% 4.05%
The percentage of cash held in the portfolio is: 104.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.26% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.86% 0%
ORGO Organogenesis Holdings Inc. Buy 12.86% 0%
CUTR Cutera, Inc. Sell -6.28% 0%
FATE Fate Therapeutics, Inc. Sell -6.3% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.17% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.63% 0%
AXSM Axsome Therapeutics, Inc. Sell -5.63% 0%
The percentage of cash held in the portfolio is: 92.02%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
Asset Action Perf %
CERS Buy All 19.43%
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.17% 0%
CERS Cerus Corporation Sell -4.85% 19.91%
CUTR Cutera, Inc. Sell -6.29% 0%
FATE Fate Therapeutics, Inc. Sell -6.29% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -6.29% 0%
The percentage of cash held in the portfolio is: 111.54%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-10-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Sell -5% 17.54%
The percentage of cash held in the portfolio is: 105%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All -1.88%
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Sell -6.18% -1.88%
CERS Cerus Corporation Sell -5.03% 17.06%
The percentage of cash held in the portfolio is: 111.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Buy All 3.4%
PODD Sell All 13.51%
Assets Rebalanced
None
2024-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 23.45% 15.17%
AVXL Anavex Life Sciences Corp. Sell -5.93% 3.57%
VREX Varex Imaging Corporation Sell -6.1% -0.85%
CERS Cerus Corporation Sell -5.1% 15.64%
The percentage of cash held in the portfolio is: 93.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All -4.63%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 23.49% 16.82%
STAA STAAR Surgical Company Sell -6.2% 4.11%
AVXL Anavex Life Sciences Corp. Sell -5.63% 7.31%
VREX Varex Imaging Corporation Sell -5.93% 0.6%
CERS Cerus Corporation Sell -5.01% 16.11%
The percentage of cash held in the portfolio is: 99.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 8.57%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 13.29% 8%
PODD Insulet Corporation Buy 23.44% 16.92%
NVCR NovoCure Limited Buy 18.46% -8.98%
STAA STAAR Surgical Company Sell -6.43% 0.25%
AVXL Anavex Life Sciences Corp. Sell -5.73% 5.44%
VREX Varex Imaging Corporation Sell -5.64% 5.21%
CERS Cerus Corporation Sell -5.08% 14.69%
The percentage of cash held in the portfolio is: 67.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 13.36% 9.14%
PODD Insulet Corporation Buy 23.31% 16.9%
NVCR NovoCure Limited Buy 18.47% -8.42%
MYGN Myriad Genetics, Inc. Buy 9.28% -0.15%
STAA STAAR Surgical Company Sell -6.02% 6.21%
AVXL Anavex Life Sciences Corp. Sell -5.62% 6.63%
VREX Varex Imaging Corporation Sell -5.97% -0.77%
CERS Cerus Corporation Sell -4.99% 15.64%
The percentage of cash held in the portfolio is: 58.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 13.28% 10.29%
PODD Insulet Corporation Buy 22.7% 15.73%
ESPR Esperion Therapeutics, Inc. Buy 5.56% -8.2%
NVCR NovoCure Limited Buy 19.19% -3.32%
MYGN Myriad Genetics, Inc. Buy 9.37% 2.48%
STAA STAAR Surgical Company Sell -5.93% 6.12%
AVXL Anavex Life Sciences Corp. Sell -5.68% 4.08%
VREX Varex Imaging Corporation Sell -5.37% 7.78%
CERS Cerus Corporation Sell -4.97% 14.69%
The percentage of cash held in the portfolio is: 51.85%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 6.76%
Assets Rebalanced
None
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 11.86% 13.89%
AADI Aadi Bioscience, Inc. Buy 12.59% 5.14%
PODD Insulet Corporation Buy 22.49% 15.22%
ESPR Esperion Therapeutics, Inc. Buy 5.86% -2.73%
NVCR NovoCure Limited Buy 19.71% -0.17%
MYGN Myriad Genetics, Inc. Buy 9.65% 6.04%
STAA STAAR Surgical Company Sell -6.24% 0.59%
AVXL Anavex Life Sciences Corp. Sell -5.47% 7.14%
VREX Varex Imaging Corporation Sell -5.5% 5.04%
CERS Cerus Corporation Sell -5.41% 6.64%
The percentage of cash held in the portfolio is: 40.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All -8.6%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 11.69% 11.15%
AADI Aadi Bioscience, Inc. Buy 12.99% 7.43%
PODD Insulet Corporation Buy 22.55% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 5.85% -3.83%
NVCR NovoCure Limited Buy 19.83% -0.5%
MYGN Myriad Genetics, Inc. Buy 9.5% 3.45%
CDMO Avid Bioservices, Inc. Sell -6.84% -6.71%
STAA STAAR Surgical Company Sell -6.15% 3.06%
AVXL Anavex Life Sciences Corp. Sell -5.77% 3.06%
VREX Varex Imaging Corporation Sell -5.77% 1.45%
CERS Cerus Corporation Sell -5.71% 2.37%
The percentage of cash held in the portfolio is: 47.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -8.89%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.62% -1.69%
AGEN Agenus Inc. Buy 10.79% -0.18%
AADI Aadi Bioscience, Inc. Buy 12.65% 1.71%
PODD Insulet Corporation Buy 22.45% 10.8%
TVTX Travere Therapeutics, Inc. Buy 8.37% 33.75%
ESPR Esperion Therapeutics, Inc. Buy 5.92% -5.46%
NVCR NovoCure Limited Buy 19.19% -6.37%
MYGN Myriad Genetics, Inc. Buy 9.47% 0.26%
CDMO Avid Bioservices, Inc. Sell -6.54% 0.85%
STAA STAAR Surgical Company Sell -6.07% 6.89%
AVXL Anavex Life Sciences Corp. Sell -5.21% 14.88%
VREX Varex Imaging Corporation Sell -5.84% 2.99%
CERS Cerus Corporation Sell -5.85% 2.84%
The percentage of cash held in the portfolio is: 30.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.72% 0.21%
CARA Cara Therapeutics, Inc. Buy 9.67% -9.62%
AGEN Agenus Inc. Buy 10.03% -6.22%
AADI Aadi Bioscience, Inc. Buy 12.73% 3.43%
PODD Insulet Corporation Buy 21.5% 7.2%
TVTX Travere Therapeutics, Inc. Buy 8.29% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 5.75% -7.1%
NVCR NovoCure Limited Buy 18.67% -7.98%
MYGN Myriad Genetics, Inc. Buy 9.41% 0.63%
CDMO Avid Bioservices, Inc. Sell -5.52% 15.41%
STAA STAAR Surgical Company Sell -5.99% 7.17%
AVXL Anavex Life Sciences Corp. Sell -5.31% 12.41%
VREX Varex Imaging Corporation Sell -5.21% 12.56%
CERS Cerus Corporation Sell -5.7% 4.27%
The percentage of cash held in the portfolio is: 20.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 11.15% 3%
CARA Cara Therapeutics, Inc. Buy 10.17% -6.12%
AGEN Agenus Inc. Buy 9.8% -9.51%
AADI Aadi Bioscience, Inc. Buy 13.03% 4.57%
PODD Insulet Corporation Buy 21.32% 5.05%
TVTX Travere Therapeutics, Inc. Buy 7.17% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 5.65% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 19.93% -3.01%
NVCR NovoCure Limited Buy 19.2% -6.48%
MYGN Myriad Genetics, Inc. Buy 9.46% 0%
CDMO Avid Bioservices, Inc. Sell -5.51% 16.54%
STAA STAAR Surgical Company Sell -6.28% 3.86%
AVXL Anavex Life Sciences Corp. Sell -5.37% 12.41%
VREX Varex Imaging Corporation Sell -5.95% 1.28%
CERS Cerus Corporation Sell -5.77% 4.27%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.59% -1.42%
ORGO Organogenesis Holdings Inc. Buy 10.03% -6.71%
CARA Cara Therapeutics, Inc. Buy 10.06% -6.41%
AGEN Agenus Inc. Buy 9.83% -8.59%
AADI Aadi Bioscience, Inc. Buy 12.72% 2.86%
PODD Insulet Corporation Buy 21.31% 5.72%
TVTX Travere Therapeutics, Inc. Buy 6.44% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 5.85% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 20.4% 0%
NVCR NovoCure Limited Buy 20.39% 0%
CDMO Avid Bioservices, Inc. Sell -5.58% 14.93%
STAA STAAR Surgical Company Sell -6.25% 3.61%
AVXL Anavex Life Sciences Corp. Sell -5.76% 5.44%
VREX Varex Imaging Corporation Sell -6.12% -2.31%
CERS Cerus Corporation Sell -5.9% 1.42%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.25% -5.21%
ORGO Organogenesis Holdings Inc. Buy 10.31% -4.59%
CARA Cara Therapeutics, Inc. Buy 10.15% -6.12%
AGEN Agenus Inc. Buy 9.59% -11.33%
AADI Aadi Bioscience, Inc. Buy 12.8% 2.86%
PODD Insulet Corporation Buy 21.08% 3.96%
TVTX Travere Therapeutics, Inc. Buy 6.55% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 6.23% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 20.52% 0%
CDMO Avid Bioservices, Inc. Sell -5.76% 12.67%
STAA STAAR Surgical Company Sell -6.35% 2.72%
AVXL Anavex Life Sciences Corp. Sell -5.85% 4.42%
VREX Varex Imaging Corporation Sell -6.02% 0%
CERS Cerus Corporation Sell -6.02% 0%
The percentage of cash held in the portfolio is: 22.52%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.53% -2.65%
ORGO Organogenesis Holdings Inc. Buy 10.44% -3.53%
CARA Cara Therapeutics, Inc. Buy 10.45% -3.5%
AGEN Agenus Inc. Buy 9.8% -9.51%
CERS Cerus Corporation Buy 11.46% -7.98%
AADI Aadi Bioscience, Inc. Buy 12.38% -0.57%
PODD Insulet Corporation Buy 20.52% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 18.18% -10.38%
TVTX Travere Therapeutics, Inc. Buy 6.27% 0%
ESPR Esperion Therapeutics, Inc. Buy 6.27% 0%
CDMO Avid Bioservices, Inc. Sell -6.07% 8.03%
STAA STAAR Surgical Company Sell -6.52% 0.15%
AVXL Anavex Life Sciences Corp. Sell -5.69% 7.14%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.91% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.83% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.63% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.66% 3.79%
AGEN Agenus Inc. Buy 9.59% -6.58%
CERS Cerus Corporation Buy 11.12% -5.88%
AADI Aadi Bioscience, Inc. Buy 11.34% -4%
NEOG Neogen Corporation Buy 16.41% -2.15%
PODD Insulet Corporation Buy 19.25% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 19.25% 0%
CDMO Avid Bioservices, Inc. Sell -6.05% 3.4%
STAA STAAR Surgical Company Sell -6.11% 1.42%
PINC Premier, Inc. Sell -6.21% -0.3%
AVXL Anavex Life Sciences Corp. Sell -5.81% 0%
VERU Veru Inc. Sell -5.81% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AVXL
  • VERU
  • PODD
  • EGRX
Assets Removed
Asset Action Perf %
EGRX Buy All -9.7%
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.75% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.92% -0.64%
ORGO Organogenesis Holdings Inc. Buy 10.37% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.46% 4.66%
AGEN Agenus Inc. Buy 10.28% 2.93%
CERS Cerus Corporation Buy 11.2% -2.52%
AADI Aadi Bioscience, Inc. Buy 11.03% -4%
NEOG Neogen Corporation Buy 16.32% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -6% -0.42%
CDMO Avid Bioservices, Inc. Sell -5.93% 2.74%
STAA STAAR Surgical Company Sell -6.03% 0%
PINC Premier, Inc. Sell -6.03% 0%
The percentage of cash held in the portfolio is: 34.64%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
Asset Action Perf %
CYH Sell All 4.72%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.75% 6.09%
ARDX Ardelyx, Inc. Buy 9.67% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.76% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.46% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.54% 7.87%
AGEN Agenus Inc. Buy 10.49% 7.31%
CERS Cerus Corporation Buy 11.24% 0%
AADI Aadi Bioscience, Inc. Buy 11.24% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.79% 0.84%
CDMO Avid Bioservices, Inc. Sell -5.84% 2.08%
The percentage of cash held in the portfolio is: 24.48%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.12% -0.59%
ARDX Ardelyx, Inc. Buy 9.91% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 10.01% 0.64%
ORGO Organogenesis Holdings Inc. Buy 10.3% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.09% 1.46%
AGEN Agenus Inc. Buy 10.55% 6.03%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.72% 3.8%
CDMO Avid Bioservices, Inc. Sell -6.07% 0%
The percentage of cash held in the portfolio is: 47.82%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.94% -4.32%
ARDX Ardelyx, Inc. Buy 9.68% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 10.01% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.9% -2.83%
CARA Cara Therapeutics, Inc. Buy 10.2% 0%
AGEN Agenus Inc. Buy 10.2% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.71% 6.33%
The percentage of cash held in the portfolio is: 42.79%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.95% -2.95%
ARDX Ardelyx, Inc. Buy 10.06% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 10.06% 0%
ORGO Organogenesis Holdings Inc. Buy 10.06% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.47% 9.07%
The percentage of cash held in the portfolio is: 62.35%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.15% -1.57%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.75% 4.43%
The percentage of cash held in the portfolio is: 92.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Buy All 0.74%
RCM Sell All 7.37%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 12.24% 7.37%
CYH Community Health Systems, Inc. Buy 12.64% -4.91%
PODD Insulet Corporation Sell -5.81% 6.55%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.17% 13.71%
The percentage of cash held in the portfolio is: 86.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 13.64%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.47% -3.03%
RCM R1 RCM Inc. Buy 12.54% 7.14%
CYH Community Health Systems, Inc. Buy 12.6% -7.66%
PODD Insulet Corporation Sell -6.24% 2.34%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.52% 10.34%
The percentage of cash held in the portfolio is: 76.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.64% -0.76%
RCM R1 RCM Inc. Buy 12.44% 7.06%
CYH Community Health Systems, Inc. Buy 12.83% -5.3%
RMD ResMed Inc. Buy 14.78% 3.67%
PODD Insulet Corporation Sell -6.2% 2.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.62% 8.02%
The percentage of cash held in the portfolio is: 61.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -10.51%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.56% -8.52%
OPK OPKO Health, Inc. Buy 10.84% 2.27%
RCM R1 RCM Inc. Buy 12.39% 7.83%
CYH Community Health Systems, Inc. Buy 13.14% -1.96%
RMD ResMed Inc. Buy 15.15% 7.5%
PODD Insulet Corporation Sell -6.32% -0.76%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.86% 2.95%
The percentage of cash held in the portfolio is: 51.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.52% -8.24%
OPK OPKO Health, Inc. Buy 11.01% 4.55%
RCM R1 RCM Inc. Buy 12.38% 8.44%
CYH Community Health Systems, Inc. Buy 13.1% -1.57%
HQY HealthEquity, Inc. Buy 12.8% -3.84%
HCSG Healthcare Services Group, Inc. Buy 2.9% -3.72%
RMD ResMed Inc. Buy 14.44% 3.13%
PODD Insulet Corporation Sell -6.3% -1.17%
EGRX Eagle Pharmaceuticals, Inc. Sell -6.05% -0.84%
The percentage of cash held in the portfolio is: 36.2%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.32% 1.14%
OPK OPKO Health, Inc. Buy 11.13% 7.58%
RCM R1 RCM Inc. Buy 11.09% -1.15%
FATE Fate Therapeutics, Inc. Buy 8.92% -4.31%
CYH Community Health Systems, Inc. Buy 13.52% 3.34%
HQY HealthEquity, Inc. Buy 12.68% -3.09%
HCSG Healthcare Services Group, Inc. Buy 2.92% -1.12%
RMD ResMed Inc. Buy 14.11% 2.5%
PODD Insulet Corporation Sell -6.1% 0.31%
EGRX Eagle Pharmaceuticals, Inc. Sell -6% -1.69%
The percentage of cash held in the portfolio is: 27.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 27.55%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.7% 26.42%
PDSB PDS Biotechnology Corporation Buy 10.14% -1.7%
OPK OPKO Health, Inc. Buy 11.34% 8.33%
RCM R1 RCM Inc. Buy 11.23% -1%
FATE Fate Therapeutics, Inc. Buy 8.68% -7.9%
CYH Community Health Systems, Inc. Buy 13.41% 1.38%
HQY HealthEquity, Inc. Buy 12.81% -3.16%
HCSG Healthcare Services Group, Inc. Buy 2.98% -0.43%
RMD ResMed Inc. Buy 13.91% 0%
PODD Insulet Corporation Sell -6.15% 0.6%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.96% 0%
The percentage of cash held in the portfolio is: 15.91%
New Assets Added
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.72% 30.89%
PDSB PDS Biotechnology Corporation Buy 10.82% 8.52%
OPK OPKO Health, Inc. Buy 10.96% 8.33%
RCM R1 RCM Inc. Buy 10.69% -2.61%
FATE Fate Therapeutics, Inc. Buy 8.85% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 10.27% -4.26%
SMTI Sanara MedTech Inc. Buy 12.09% -5.45%
CYH Community Health Systems, Inc. Buy 13.02% 1.77%
HQY HealthEquity, Inc. Buy 12.57% -1.69%
HCSG Healthcare Services Group, Inc. Buy 2.89% 0%
PODD Insulet Corporation Sell -5.89% 1.61%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.02% 26.12%
PDSB PDS Biotechnology Corporation Buy 10.73% 10.23%
OPK OPKO Health, Inc. Buy 11.08% 12.12%
RCM R1 RCM Inc. Buy 10.69% -0.19%
FATE Fate Therapeutics, Inc. Buy 8.69% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 9.53% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 10.64% 1.6%
SMTI Sanara MedTech Inc. Buy 12.49% 0%
CYH Community Health Systems, Inc. Buy 12.49% 0%
HQY HealthEquity, Inc. Buy 12.49% 0%
PODD Insulet Corporation Sell -5.79% 0.85%
RMD ResMed Inc. Sell -6.05% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 10.86% 23.69%
PDSB PDS Biotechnology Corporation Buy 10.94% 11.93%
OPK OPKO Health, Inc. Buy 10.67% 7.58%
RCM R1 RCM Inc. Buy 10.67% -0.84%
FATE Fate Therapeutics, Inc. Buy 8.66% -3.05%
PTGX Protagonist Therapeutics, Inc. Buy 9.87% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 10.52% 0%
PODD Insulet Corporation Sell -5.75% 2.09%
The percentage of cash held in the portfolio is: 33.55%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
CYH Sell All 48.75%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.4% 35.31%
VRDN Viridian Therapeutics, Inc. Buy 10.74% 19.76%
PDSB PDS Biotechnology Corporation Buy 10.69% 6.96%
OPK OPKO Health, Inc. Buy 10.9% 7.58%
RCM R1 RCM Inc. Buy 11.09% 0.92%
FATE Fate Therapeutics, Inc. Buy 8.49% -7%
PTGX Protagonist Therapeutics, Inc. Buy 10.17% 0%
PODD Insulet Corporation Sell -5.98% 0.3%
The percentage of cash held in the portfolio is: 32.5%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
EGRX Sell All 20.09%
ACAD Sell All 16.37%
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 10.91% 28.79%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.58% 14.55%
CYH Community Health Systems, Inc. Buy 10.45% 26.56%
VRDN Viridian Therapeutics, Inc. Buy 10.39% 18.17%
PDSB PDS Biotechnology Corporation Buy 11.78% 20.17%
OPK OPKO Health, Inc. Buy 10.85% 9.09%
RCM R1 RCM Inc. Buy 11.11% 3.07%
FATE Fate Therapeutics, Inc. Buy 8.96% 0%
PODD Insulet Corporation Sell -5.94% -0.92%
The percentage of cash held in the portfolio is: 19.91%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 11.11% 29.24%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.71% 14.17%
CYH Community Health Systems, Inc. Buy 10.35% 23.44%
VRDN Viridian Therapeutics, Inc. Buy 10.12% 13.4%
PDSB PDS Biotechnology Corporation Buy 11.02% 10.8%
OPK OPKO Health, Inc. Buy 11.16% 10.61%
RCM R1 RCM Inc. Buy 11.18% 2.15%
PODD Insulet Corporation Sell -5.95% 0.37%
The percentage of cash held in the portfolio is: 29.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Buy All -22.33%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 11.21% 31.03%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.41% 11.78%
CYH Community Health Systems, Inc. Buy 9.83% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 9.73% 9.54%
PDSB PDS Biotechnology Corporation Buy 10.88% 9.94%
OPK OPKO Health, Inc. Buy 11.34% 12.88%
RCM R1 RCM Inc. Buy 11.11% 2%
FGEN FibroGen, Inc. Sell -6.36% -1.94%
PODD Insulet Corporation Sell -5.94% -0.04%
The percentage of cash held in the portfolio is: 36.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 10.98% 28.57%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.55% 13.35%
CYH Community Health Systems, Inc. Buy 9.81% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 9.71% 9.54%
PDSB PDS Biotechnology Corporation Buy 10.83% 9.66%
ALT Altimmune, Inc. Buy 9% -12.43%
OPK OPKO Health, Inc. Buy 11.54% 15.15%
RCM R1 RCM Inc. Buy 10.71% -1.46%
FGEN FibroGen, Inc. Sell -6.29% -0.97%
PODD Insulet Corporation Sell -5.93% 0%
The percentage of cash held in the portfolio is: 28.09%
New Assets Added
  • PODD
Assets Removed
Asset Action Perf %
RARE Sell All 7.35%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 11.05% 33.48%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.41% 15.55%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.83% 10.14%
CYH Community Health Systems, Inc. Buy 9.94% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 9.92% 15.37%
PDSB PDS Biotechnology Corporation Buy 10.91% 13.92%
ALT Altimmune, Inc. Buy 9.98% 0.13%
OPK OPKO Health, Inc. Buy 10.45% 7.58%
WST West Pharmaceutical Services, Inc. Buy 10.24% -1.88%
RCM R1 RCM Inc. Buy 10.54% 0%
FGEN FibroGen, Inc. Sell -6.27% -3.88%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Buy 10.92% 33.26%
ACAD ACADIA Pharmaceuticals Inc. Buy 11.09% 13.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.85% 11.57%
CYH Community Health Systems, Inc. Buy 9.73% 21.88%
VRDN Viridian Therapeutics, Inc. Buy 9.46% 11.2%
BHVN Biohaven Ltd. Buy 10.22% 6.27%
PDSB PDS Biotechnology Corporation Buy 11.37% 20.03%
ALT Altimmune, Inc. Buy 10.41% 5.61%
OPK OPKO Health, Inc. Buy 10.41% 8.33%
WST West Pharmaceutical Services, Inc. Buy 9.91% -3.96%
FGEN FibroGen, Inc. Sell -6.15% -2.91%
The percentage of cash held in the portfolio is: 2.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Buy All -10.22%
Assets Rebalanced
Asset Action Weight
WST Sell -1.07%
CYH Sell -1.56%
VRDN Sell -2.19%
ALT Sell -1.6%
OPK Sell -1.91%
2024-07-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.09% 11.9%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.17% 34.37%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.15% 13.27%
CYH Community Health Systems, Inc. Buy 11.17% 18.75%
VRDN Viridian Therapeutics, Inc. Buy 11.17% 5.15%
OPK OPKO Health, Inc. Buy 12.07% 4.55%
ALT Altimmune, Inc. Buy 12.19% 5.61%
BHVN Biohaven Ltd. Buy 10.27% 5.28%
PDSB PDS Biotechnology Corporation Buy 11.17% 16.19%
WST West Pharmaceutical Services, Inc. Buy 11.24% -3.1%
FGEN FibroGen, Inc. Sell -6.12% -0.97%
APLS Apellis Pharmaceuticals, Inc. Sell -7.57% -8.93%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Buy All -25%
Assets Rebalanced
Asset Action Weight
BHVN Sell -1.88%
RARE Sell -2.22%
EGRX Sell -2.15%
PDSB Sell -2.24%
CYH Sell -3.95%
VRDN Sell -4.24%
WST Buy 8.21%
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.27% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.64% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 12.3% 10.14%
CYH Community Health Systems, Inc. Buy 15.09% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 14.69% -1.97%
PDSB PDS Biotechnology Corporation Buy 13.01% 10.23%
BHVN Biohaven Ltd. Buy 12.38% 4.89%
ALT Altimmune, Inc. Buy 12.12% 2.67%
OPK OPKO Health, Inc. Buy 12.25% 3.79%
WST West Pharmaceutical Services, Inc. Buy 3.12% 0%
FGEN FibroGen, Inc. Sell -5.89% 4.95%
SGMO Sangamo Therapeutics, Inc. Sell -8.35% -22.22%
APLS Apellis Pharmaceuticals, Inc. Sell -7.62% -7.16%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
Assets Removed
Asset Action Perf %
NVRO Buy All -10.68%
PAHC Buy All -6.77%
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.37% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 14.22% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 12.38% 6.55%
CYH Community Health Systems, Inc. Buy 14.14% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 14.48% -7.12%
PDSB PDS Biotechnology Corporation Buy 12.28% 0%
BHVN Biohaven Ltd. Buy 12.28% 0%
ALT Altimmune, Inc. Buy 12.28% 0%
OPK OPKO Health, Inc. Buy 12.28% 0%
NVRO Nevro Corp. Sell 14.51% -0.63%
FGEN FibroGen, Inc. Sell -5.65% 12.33%
SGMO Sangamo Therapeutics, Inc. Sell -7.9% -11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -7.63% -3.17%
PAHC Phibro Animal Health Corporation Sell -23.33% 0%
The percentage of cash held in the portfolio is: 14.28%
New Assets Added
  • PAHC
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.24% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.8% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.59% 0.9%
CYH Community Health Systems, Inc. Buy 14.1% 5.31%
VRDN Viridian Therapeutics, Inc. Buy 14.29% -7.27%
NVRO Nevro Corp. Sell 15% -5.28%
FGEN FibroGen, Inc. Sell -4.28% 32.91%
SGMO Sangamo Therapeutics, Inc. Sell -6.25% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -7.13% 2.42%
The percentage of cash held in the portfolio is: 39.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.4% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.18% 16.74%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.81% 2.79%
STAA STAAR Surgical Company Buy 12.09% 5.2%
CYH Community Health Systems, Inc. Buy 14.35% 7.19%
VRDN Viridian Therapeutics, Inc. Buy 14.19% -7.95%
NVRO Nevro Corp. Sell 14.95% -4.9%
FGEN FibroGen, Inc. Sell -4.6% 27.86%
SGMO Sangamo Therapeutics, Inc. Sell -6.25% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -7.05% 3.61%
The percentage of cash held in the portfolio is: 27.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.67% 1.01%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.81% 23.44%
MNKD MannKind Corporation Buy 8.97% -6.26%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.88% 3.19%
STAA STAAR Surgical Company Buy 11.81% 12.05%
CYH Community Health Systems, Inc. Buy 12.75% 3.75%
ARDX Ardelyx, Inc. Buy 14.19% 2.16%
CHRS Coherus BioSciences, Inc. Buy 12.93% -6.94%
NVRO Nevro Corp. Sell 14.15% -8.17%
VRDN Viridian Therapeutics, Inc. Buy 14.15% 0%
FGEN FibroGen, Inc. Sell -4.37% 25.24%
SGMO Sangamo Therapeutics, Inc. Sell -5.91% 8.33%
APLS Apellis Pharmaceuticals, Inc. Sell -6.71% 0%
The percentage of cash held in the portfolio is: -4.3%
New Assets Added
  • APLS
  • NVRO
  • VRDN
Assets Removed
Asset Action Perf %
MODV Buy All -8.11%
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.75% 2.33%
MNKD MannKind Corporation Buy 9.16% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.91% 25%
STAA STAAR Surgical Company Buy 11.81% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.82% 3.14%
CYH Community Health Systems, Inc. Buy 12.84% 5%
ARDX Ardelyx, Inc. Buy 13.82% 0%
CHRS Coherus BioSciences, Inc. Buy 13.82% 0%
NVRO Nevro Corp. Sell -6.13% -5.78%
MODV ModivCare Inc. Sell -5.99% -4.83%
FGEN FibroGen, Inc. Sell -5.04% 13.4%
SGMO Sangamo Therapeutics, Inc. Sell -6.42% 0%
The percentage of cash held in the portfolio is: 29.65%
New Assets Added
  • SGMO
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.05% 3.09%
MNKD MannKind Corporation Buy 9.5% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.92% 12.05%
STAA STAAR Surgical Company Buy 11.87% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.16% 3.94%
CYH Community Health Systems, Inc. Buy 12.52% 0%
NVRO Nevro Corp. Sell -6.23% -5.03%
MODV ModivCare Inc. Sell -5.9% -0.84%
FGEN FibroGen, Inc. Sell -5.96% 0%
The percentage of cash held in the portfolio is: 52.07%
New Assets Added
  • FGEN
  • CYH
Assets Removed
Asset Action Perf %
AVXL Buy All -12.3%
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.6% -2.39%
MNKD MannKind Corporation Buy 9.4% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.8% 9.82%
STAA STAAR Surgical Company Buy 11.65% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 11.02% 1.71%
NVRO Nevro Corp. Sell -6.41% -7.16%
MODV ModivCare Inc. Sell -5.9% 0%
AVXL Anavex Life Sciences Corp. Sell -5.9% 0%
The percentage of cash held in the portfolio is: 65.75%
New Assets Added
  • MODV
  • AVXL
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.69% -1.76%
MNKD MannKind Corporation Buy 9.51% -3.5%
FGEN FibroGen, Inc. Buy 9.61% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 1.56%
STAA STAAR Surgical Company Buy 10.86% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.86% 0%
NVRO Nevro Corp. Sell -6% 0%
The percentage of cash held in the portfolio is: 45.45%
New Assets Added
  • NVRO
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.8% 0%
MNKD MannKind Corporation Buy 9.8% 0%
FGEN FibroGen, Inc. Buy 9.8% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-06-21 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 6.86%
Assets Rebalanced
None
2024-06-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
EGRX Eagle Pharmaceuticals, Inc. Sell -4.48% 11.9%
The percentage of cash held in the portfolio is: 104.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
VKTX Buy All 24.67%
Assets Rebalanced
None
2024-06-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
VKTX Viking Therapeutics, Inc. Sell -5.84% 23.65%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.28% 15.79%
The percentage of cash held in the portfolio is: 110.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
RVNC Buy All 11.45%
Assets Rebalanced
None
2024-06-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
RVNC Revance Therapeutics, Inc. Sell -2.82% 12.35%
VKTX Viking Therapeutics, Inc. Sell -6.24% 18.58%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.13% 18.99%
The percentage of cash held in the portfolio is: 113.19%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All 1.76%
Assets Rebalanced
None
2024-06-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 12.38% 8.16%
RVNC Revance Therapeutics, Inc. Sell -2.75% 14.46%
VKTX Viking Therapeutics, Inc. Sell -6.9% 9.85%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.04% 20.59%
The percentage of cash held in the portfolio is: 101.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Sell All 17.73%
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 11.35% 14.89%
OMCL Omnicell, Inc. Buy 12.15% 5.58%
RVNC Revance Therapeutics, Inc. Sell -2.72% 15.66%
VKTX Viking Therapeutics, Inc. Sell -7.11% 7.6%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.91% 23.57%
The percentage of cash held in the portfolio is: 90.24%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Sell All 5.56%
Assets Rebalanced
None
2024-05-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 14.09% 14.81%
INGN Inogen, Inc. Buy 11.89% 21.99%
OMCL Omnicell, Inc. Buy 12.21% 7.53%
RVNC Revance Therapeutics, Inc. Sell -2.56% 19.58%
VKTX Viking Therapeutics, Inc. Sell -7.18% 5.36%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.52% 10.3%
The percentage of cash held in the portfolio is: 76.08%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Buy All 15.9%
MDRX Buy All -16.51%
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 13.38% 11.11%
INGN Inogen, Inc. Buy 11.95% 24.96%
OMCL Omnicell, Inc. Buy 12.07% 8.3%
NVRO Nevro Corp. Sell -5.88% 17.05%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.09% -0.53%
RVNC Revance Therapeutics, Inc. Sell -2.55% 18.37%
VKTX Viking Therapeutics, Inc. Sell -6.77% 9.14%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.23% 14.42%
The percentage of cash held in the portfolio is: 91.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -11.24%
SENS Sell All -8.83%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 12.04% -2.91%
SENS Senseonics Holdings, Inc. Buy 11.34% -7.8%
SGMO Sangamo Therapeutics, Inc. Buy 13.77% 14.81%
INGN Inogen, Inc. Buy 11.14% 17.02%
OMCL Omnicell, Inc. Buy 11.67% 5.21%
NVRO Nevro Corp. Sell -5.85% 17.05%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.32% -3.46%
RVNC Revance Therapeutics, Inc. Sell -2.5% 19.58%
VKTX Viking Therapeutics, Inc. Sell -6.61% 10.85%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.21% 14.65%
The percentage of cash held in the portfolio is: 68.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 12.35% 1.85%
SENS Senseonics Holdings, Inc. Buy 11.75% -2.26%
SGMO Sangamo Therapeutics, Inc. Buy 13.89% 18.52%
INGN Inogen, Inc. Buy 11.41% 22.55%
OMCL Omnicell, Inc. Buy 11.61% 7%
VCYT Veracyte, Inc. Buy 10.34% -3.91%
NVRO Nevro Corp. Sell -5.98% 13.34%
MDRX Allscripts Healthcare Solutions, Inc. Sell -8.91% -1.2%
RVNC Revance Therapeutics, Inc. Sell -2.68% 12.05%
VKTX Viking Therapeutics, Inc. Sell -6.62% 8.76%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.2% 12.81%
The percentage of cash held in the portfolio is: 57.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -2.32%
ACRS Sell All -8.73%
Assets Rebalanced
None
2024-05-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 12.33% -0.26%
SENS Senseonics Holdings, Inc. Buy 11.83% -3.49%
SGMO Sangamo Therapeutics, Inc. Buy 13.28% 11.11%
ACRS Aclaris Therapeutics, Inc. Buy 11.19% -6.35%
INGN Inogen, Inc. Buy 11.59% 22.13%
OMCL Omnicell, Inc. Buy 11.71% 5.91%
VCYT Veracyte, Inc. Buy 10.62% -3.2%
PODD Insulet Corporation Buy 19.48% -1.4%
NVRO Nevro Corp. Sell -6.19% 12.01%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.21% -2.53%
RVNC Revance Therapeutics, Inc. Sell -2.81% 9.34%
VKTX Viking Therapeutics, Inc. Sell -6.88% 6.99%
EGRX Eagle Pharmaceuticals, Inc. Sell -4.91% 0%
The percentage of cash held in the portfolio is: 27.95%
New Assets Added
  • EGRX
Assets Removed
Asset Action Perf %
FOLD Buy All -7.37%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 12.32% -0.79%
SENS Senseonics Holdings, Inc. Buy 11.86% -3.7%
SGMO Sangamo Therapeutics, Inc. Buy 13.57% 12.96%
ACRS Aclaris Therapeutics, Inc. Buy 11.34% -5.56%
INGN Inogen, Inc. Buy 11.85% 24.26%
OMCL Omnicell, Inc. Buy 11.33% 1.99%
VCYT Veracyte, Inc. Buy 10.93% -0.89%
PODD Insulet Corporation Buy 19.72% -0.67%
NVRO Nevro Corp. Sell -6.57% 7.07%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.31% -3.2%
FOLD Amicus Therapeutics, Inc. Sell -3.29% -5.63%
RVNC Revance Therapeutics, Inc. Sell -2.97% 4.82%
VKTX Viking Therapeutics, Inc. Sell -7.26% 2.24%
The percentage of cash held in the portfolio is: 26.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTCT Sell All 40.43%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.83% 15.84%
CARA Cara Therapeutics, Inc. Buy 12.41% -0.79%
SENS Senseonics Holdings, Inc. Buy 12.34% -0.41%
SGMO Sangamo Therapeutics, Inc. Buy 14.55% 20.37%
ACRS Aclaris Therapeutics, Inc. Buy 11.42% -5.56%
INGN Inogen, Inc. Buy 12.02% 25.25%
OMCL Omnicell, Inc. Buy 11.3% 1.03%
VCYT Veracyte, Inc. Buy 11.28% 1.69%
PODD Insulet Corporation Buy 20.18% 1.02%
NVRO Nevro Corp. Sell -7.17% -0.71%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.13% -0.53%
FOLD Amicus Therapeutics, Inc. Sell -3.25% -3.68%
RVNC Revance Therapeutics, Inc. Sell -2.85% 9.04%
VKTX Viking Therapeutics, Inc. Sell -7.25% 2.98%
The percentage of cash held in the portfolio is: 12.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Sell All -14.91%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 12.08% 19.11%
CARA Cara Therapeutics, Inc. Buy 13.22% 6.48%
IBRX ImmunityBio, Inc. Buy 10.37% -13.79%
SENS Senseonics Holdings, Inc. Buy 12.44% 1.03%
SGMO Sangamo Therapeutics, Inc. Buy 13.56% 12.96%
ACRS Aclaris Therapeutics, Inc. Buy 11.24% -6.35%
INGN Inogen, Inc. Buy 12.1% 26.95%
OMCL Omnicell, Inc. Buy 11.67% 5.08%
VCYT Veracyte, Inc. Buy 11.46% 4%
PODD Insulet Corporation Buy 19.84% 0%
NVRO Nevro Corp. Sell -6.97% 1.33%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.43% -4.53%
FOLD Amicus Therapeutics, Inc. Sell -3.21% -2.93%
RVNC Revance Therapeutics, Inc. Sell -2.97% 4.82%
VKTX Viking Therapeutics, Inc. Sell -7.43% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VKTX
  • PODD
Assets Removed
Asset Action Perf %
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 12.01% 17.82%
CARA Cara Therapeutics, Inc. Buy 12.54% 0.53%
IBRX ImmunityBio, Inc. Buy 10.88% -9.9%
SENS Senseonics Holdings, Inc. Buy 12.59% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 12.95% 7.41%
ACRS Aclaris Therapeutics, Inc. Buy 11.29% -6.35%
INGN Inogen, Inc. Buy 12.01% 25.39%
OMCL Omnicell, Inc. Buy 11.06% -0.86%
VCYT Veracyte, Inc. Buy 11.59% 4.67%
MD Pediatrix Medical Group, Inc. Buy 13.14% -3.87%
NVRO Nevro Corp. Sell -6.62% 6.71%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.05% 0.13%
FOLD Amicus Therapeutics, Inc. Sell -3.28% -4.66%
RVNC Revance Therapeutics, Inc. Sell -3.12% 0.3%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ITGR Buy All -7.43%
Assets Rebalanced
Asset Action Weight
IBRX Sell -1.74%
OMCL Sell -2.4%
PTCT Sell -2.9%
INGN Sell -3.11%
MD Buy 1.37%
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 14.24% 10.96%
IBRX ImmunityBio, Inc. Buy 13.65% -4%
CARA Cara Therapeutics, Inc. Buy 12.55% -0.79%
SENS Senseonics Holdings, Inc. Buy 11.44% -8.83%
ACRS Aclaris Therapeutics, Inc. Buy 11.46% -6.35%
INGN Inogen, Inc. Buy 15.29% 25.04%
SGMO Sangamo Therapeutics, Inc. Buy 12.46% 1.85%
OMCL Omnicell, Inc. Buy 14.08% 2.22%
MD Pediatrix Medical Group, Inc. Buy 11.23% 0%
VCYT Veracyte, Inc. Buy 11.23% 0%
NVRO Nevro Corp. Sell -6.48% 9.98%
ITGR Integer Holdings Corporation Sell -7.4% -2.84%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.45% -2.8%
FOLD Amicus Therapeutics, Inc. Sell -3.11% 2.06%
RVNC Revance Therapeutics, Inc. Sell -3.18% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 14.68% 12.88%
IBRX ImmunityBio, Inc. Buy 13.01% -9.68%
CARA Cara Therapeutics, Inc. Buy 12.15% -5.29%
SENS Senseonics Holdings, Inc. Buy 12.17% -4.31%
ACRS Aclaris Therapeutics, Inc. Buy 11.51% -7.14%
INGN Inogen, Inc. Buy 14.88% 20%
SGMO Sangamo Therapeutics, Inc. Buy 12.86% 3.7%
OMCL Omnicell, Inc. Buy 13.95% -0.03%
NVRO Nevro Corp. Sell -6.31% 13.52%
ITGR Integer Holdings Corporation Sell -7.59% -4.01%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.66% -3.73%
FOLD Amicus Therapeutics, Inc. Sell -3.22% 0%
RVNC Revance Therapeutics, Inc. Sell -3.22% 0%
The percentage of cash held in the portfolio is: 24.79%
New Assets Added
  • FOLD
  • RVNC
Assets Removed
Asset Action Perf %
NUTX Buy All 35.35%
FATE Buy All 34.93%
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 13.79% 8.68%
IBRX ImmunityBio, Inc. Buy 12.6% -10.34%
CARA Cara Therapeutics, Inc. Buy 12.58% 0.53%
SENS Senseonics Holdings, Inc. Buy 12.25% -1.23%
ACRS Aclaris Therapeutics, Inc. Buy 11.76% -2.78%
INGN Inogen, Inc. Buy 14.91% 23.26%
SGMO Sangamo Therapeutics, Inc. Buy 11.64% -3.7%
IOVA Iovance Biotherapeutics, Inc. Buy 12.61% 7.6%
OMCL Omnicell, Inc. Buy 13.67% 0.4%
NUTX Nutex Health Inc. Sell -3.83% 32.38%
FATE Fate Therapeutics, Inc. Sell -3.52% 37.8%
NVRO Nevro Corp. Sell -6.61% 7.16%
ITGR Integer Holdings Corporation Sell -7.42% -4.24%
MDRX Allscripts Healthcare Solutions, Inc. Sell -9.37% -3.2%
The percentage of cash held in the portfolio is: 14.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 13.79% 11.27%
IBRX ImmunityBio, Inc. Buy 12.61% -8.12%
CDMO Avid Bioservices, Inc. Buy 13.57% 15.87%
CARA Cara Therapeutics, Inc. Buy 12.8% 4.76%
SENS Senseonics Holdings, Inc. Buy 12.46% 2.87%
ACRS Aclaris Therapeutics, Inc. Buy 12.56% 6.35%
INGN Inogen, Inc. Buy 12.23% 3.55%
SGMO Sangamo Therapeutics, Inc. Buy 11.81% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 12.8% 11.84%
OMCL Omnicell, Inc. Buy 13.37% 0.56%
NUTX Nutex Health Inc. Sell -3.45% 37.6%
FATE Fate Therapeutics, Inc. Sell -3.42% 38.12%
NVRO Nevro Corp. Sell -7.08% -1.86%
ITGR Integer Holdings Corporation Sell -7.18% -3.25%
MDRX Allscripts Healthcare Solutions, Inc. Sell -8.87% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
None
Assets Rebalanced
Asset Action Weight
CDMO Buy 0.57%
OMCL Buy 0.92%
PTCT Buy 1.46%
IOVA Buy 1.74%
CARA Buy 1.82%
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.99% 15.37%
IBRX ImmunityBio, Inc. Buy 12.16% -13.13%
CARA Cara Therapeutics, Inc. Buy 11.16% 4.5%
CDMO Avid Bioservices, Inc. Buy 11.99% 11.38%
SENS Senseonics Holdings, Inc. Buy 12.78% 3.49%
INGN Inogen, Inc. Buy 12.28% 1.99%
ACRS Aclaris Therapeutics, Inc. Buy 12.52% 3.97%
SGMO Sangamo Therapeutics, Inc. Buy 11.82% -1.85%
IOVA Iovance Biotherapeutics, Inc. Buy 11.2% 11.04%
OMCL Omnicell, Inc. Buy 11.99% -0.5%
NUTX Nutex Health Inc. Sell -3.89% 31.05%
FATE Fate Therapeutics, Inc. Sell -3.79% 32.7%
NVRO Nevro Corp. Sell -6.98% 1.5%
ITGR Integer Holdings Corporation Sell -7.23% -1.96%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRI Buy All -10.12%
Assets Rebalanced
Asset Action Weight
CARA Sell -1.56%
IOVA Sell -2.18%
CDMO Sell -1.58%
OMCL Sell -1.84%
PTCT Sell -2.18%
IBRX Buy 1.58%
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 13.82% 15.54%
IBRX ImmunityBio, Inc. Buy 12.08% 1.78%
CDMO Avid Bioservices, Inc. Buy 12.95% 9.13%
CARA Cara Therapeutics, Inc. Buy 12.22% 2.94%
SENS Senseonics Holdings, Inc. Buy 12.48% 3.68%
INGN Inogen, Inc. Buy 11.9% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 12.67% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 12.8% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 12.08% 2.93%
OMCL Omnicell, Inc. Buy 13.54% 0%
NUTX Nutex Health Inc. Sell -3.83% 30.35%
FATE Fate Therapeutics, Inc. Sell -3.56% 35.25%
ATRI Atrion Corporation Sell -7.26% -5.05%
NVRO Nevro Corp. Sell -6.89% 0.27%
ITGR Integer Holdings Corporation Sell -7.01% -1.54%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OMCL
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 14.79% 19.57%
SMMT Summit Therapeutics Inc. Buy 15.07% 21.76%
IBRX ImmunityBio, Inc. Buy 11.66% -5.01%
CDMO Avid Bioservices, Inc. Buy 12.45% 1.46%
CARA Cara Therapeutics, Inc. Buy 12.32% 0.4%
SENS Senseonics Holdings, Inc. Buy 11.83% -4.93%
INGN Inogen, Inc. Buy 12.14% 0%
ACRS Aclaris Therapeutics, Inc. Buy 12.14% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 12.14% 0%
SGMO Sangamo Therapeutics, Inc. Buy 12.14% 0%
NUTX Nutex Health Inc. Sell -3.53% 37.91%
FATE Fate Therapeutics, Inc. Sell -3.7% 34.77%
ATRI Atrion Corporation Sell -7.72% -8.07%
NVRO Nevro Corp. Sell -6.57% 8.04%
ITGR Integer Holdings Corporation Sell -7.16% -0.18%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
Assets Removed
Asset Action Perf %
OPK Sell All -3.05%
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 11.31% -6.87%
PTCT PTC Therapeutics, Inc. Buy 14.52% 12.53%
SMMT Summit Therapeutics Inc. Buy 13.14% 1.81%
IBRX ImmunityBio, Inc. Buy 11.38% -11.12%
CDMO Avid Bioservices, Inc. Buy 12.92% 0.93%
CARA Cara Therapeutics, Inc. Buy 12.74% -0.53%
SENS Senseonics Holdings, Inc. Buy 12.98% 0%
NUTX Nutex Health Inc. Sell -3.67% 38.01%
FATE Fate Therapeutics, Inc. Sell -3.73% 37%
ATRI Atrion Corporation Sell -7.98% -7.16%
NVRO Nevro Corp. Sell -6.96% 6.54%
ITGR Integer Holdings Corporation Sell -7.59% -1.87%
The percentage of cash held in the portfolio is: 40.95%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 11.44% -5.34%
PTCT PTC Therapeutics, Inc. Buy 14.45% 12.5%
SMMT Summit Therapeutics Inc. Buy 12.91% 0.52%
IBRX ImmunityBio, Inc. Buy 12.74% 0%
CDMO Avid Bioservices, Inc. Buy 12.74% 0%
CARA Cara Therapeutics, Inc. Buy 12.74% 0%
NUTX Nutex Health Inc. Sell -3.78% 35.86%
FATE Fate Therapeutics, Inc. Sell -3.8% 35.57%
ATRI Atrion Corporation Sell -7.88% -6.33%
NVRO Nevro Corp. Sell -7.48% -0.88%
ITGR Integer Holdings Corporation Sell -7.75% -4.55%
The percentage of cash held in the portfolio is: 53.67%
New Assets Added
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 11.7% -3.82%
PTCT PTC Therapeutics, Inc. Buy 12.92% 0%
SMMT Summit Therapeutics Inc. Buy 12.92% 0%
NUTX Nutex Health Inc. Sell -4.02% 32.17%
FATE Fate Therapeutics, Inc. Sell -3.6% 39.39%
ATRI Atrion Corporation Sell -7.46% 0%
NVRO Nevro Corp. Sell -7.46% 0%
ITGR Integer Holdings Corporation Sell -7.46% 0%
The percentage of cash held in the portfolio is: 92.46%
New Assets Added
  • ATRI
  • NVRO
  • ITGR
  • PTCT
  • SMMT
Assets Removed
Asset Action Perf %
UTHR Buy All -1.8%
ACRS Sell All -4.76%
KIDS Sell All 4.45%
ANGO Sell All 1.93%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 13.05% -3.97%
KIDS OrthoPediatrics Corp. Buy 12.86% 5.11%
ANGO AngioDynamics, Inc. Buy 11.62% 10.7%
OPK OPKO Health, Inc. Buy 11.44% -6.11%
UTHR United Therapeutics Corporation Sell -5.87% -2.33%
NUTX Nutex Health Inc. Sell -3.24% 45.39%
FATE Fate Therapeutics, Inc. Sell -5.34% 10.05%
The percentage of cash held in the portfolio is: 65.5%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -9.75%
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 12.63% -7.94%
TNDM Tandem Diabetes Care, Inc. Buy 12.84% -2.07%
KIDS OrthoPediatrics Corp. Buy 13.55% 9.67%
ANGO AngioDynamics, Inc. Buy 12.74% 20.18%
OPK OPKO Health, Inc. Buy 11.93% -3.05%
UTHR United Therapeutics Corporation Sell -6% -3.51%
NUTX Nutex Health Inc. Sell -6% 0%
FATE Fate Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 54.31%
New Assets Added
  • NUTX
  • FATE
Assets Removed
None
Assets Rebalanced
Asset Action Weight
UTHR Buy 39.24%
2024-04-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 12.8% -5.56%
TNDM Tandem Diabetes Care, Inc. Buy 12.8% -1.16%
KIDS OrthoPediatrics Corp. Buy 12.8% 4.94%
ANGO AngioDynamics, Inc. Buy 12.8% 22.28%
OPK OPKO Health, Inc. Buy 12.8% 5.34%
UTHR United Therapeutics Corporation Sell -44.54% -3.19%
The percentage of cash held in the portfolio is: 80.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All -1111.05%
Assets Rebalanced
Asset Action Weight
ACRS Sell -31.79%
TNDM Sell -33.87%
KIDS Sell -36.75%
ANGO Sell -44.94%
OPK Sell -76.15%
2024-04-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.41% 23.33%
TNDM Tandem Diabetes Care, Inc. Buy 8.05% -4.65%
KIDS OrthoPediatrics Corp. Buy 8.01% -5.18%
ACRS Aclaris Therapeutics, Inc. Buy 7.97% -5.56%
OPK OPKO Health, Inc. Buy 15.56% 3.05%
UTHR United Therapeutics Corporation Sell -7.85% -1.67%
NUTX Nutex Health Inc. Sell -6.15% 16.84%
The percentage of cash held in the portfolio is: 63.99%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All 7.77%
MCRB Buy All 24.46%
BAX Sell All -0.86%
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 17.04% -0.19%
ANGO AngioDynamics, Inc. Buy 9.39% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 8.21% -5.1%
KIDS OrthoPediatrics Corp. Buy 7.96% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 8.37% -3.17%
OPK OPKO Health, Inc. Buy 15.94% 3.05%
SMTI Sanara MedTech Inc. Sell -3.99% 4.29%
MCRB Seres Therapeutics, Inc. Sell -3.15% 24.46%
UTHR United Therapeutics Corporation Sell -7.86% 0.5%
NUTX Nutex Health Inc. Sell -7.49% 1.05%
The percentage of cash held in the portfolio is: 55.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All -0.14%
VCYT Sell All -5.57%
THC Sell All 9.07%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.96% 10.71%
BAX Baxter International Inc. Buy 17.13% 1.3%
OMCL Omnicell, Inc. Buy 17.42% 3.02%
ANGO AngioDynamics, Inc. Buy 8.76% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 8.21% -4.11%
KIDS OrthoPediatrics Corp. Buy 8.33% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 8.56% 0%
VCYT Veracyte, Inc. Buy 8.53% -0.37%
OPK OPKO Health, Inc. Buy 15.31% 0%
SMTI Sanara MedTech Inc. Sell -4.09% 0.92%
MCRB Seres Therapeutics, Inc. Sell -3.14% 24.06%
UTHR United Therapeutics Corporation Sell -7.78% 0.64%
NUTX Nutex Health Inc. Sell -7.5% 0%
The percentage of cash held in the portfolio is: 17.31%
New Assets Added
  • NUTX
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.71% 11.48%
BAX Baxter International Inc. Buy 16.37% -0.58%
OMCL Omnicell, Inc. Buy 17.32% 5.18%
ANGO AngioDynamics, Inc. Buy 8.59% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 8.36% 0.31%
KIDS OrthoPediatrics Corp. Buy 8.39% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 8.21% -1.59%
VCYT Veracyte, Inc. Buy 8.51% 2.03%
ATRI Atrion Corporation Buy 12.15% 0%
OFIX Orthofix Medical Inc. Buy 12.15% 0%
SMTI Sanara MedTech Inc. Sell -4.05% -0.57%
MCRB Seres Therapeutics, Inc. Sell -3.08% 23.37%
UTHR United Therapeutics Corporation Sell -7.62% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • UTHR
  • ATRI
  • OFIX
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.74% 11.22%
BAX Baxter International Inc. Buy 16.43% -0.7%
OMCL Omnicell, Inc. Buy 17.41% 5.22%
ANGO AngioDynamics, Inc. Buy 8.38% 0%
TNDM Tandem Diabetes Care, Inc. Buy 8.38% 0%
KIDS OrthoPediatrics Corp. Buy 8.38% 0%
ACRS Aclaris Therapeutics, Inc. Buy 8.38% 0%
VCYT Veracyte, Inc. Buy 8.38% 0%
SMTI Sanara MedTech Inc. Sell -4.1% -1.39%
MCRB Seres Therapeutics, Inc. Sell -3.12% 22.77%
The percentage of cash held in the portfolio is: 18.75%
New Assets Added
  • ANGO
  • TNDM
  • KIDS
  • ACRS
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-03-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.57% 8.23%
BAX Baxter International Inc. Buy 16.37% -2.44%
OMCL Omnicell, Inc. Buy 16.86% 0.5%
SMTI Sanara MedTech Inc. Sell -4.17% -1.69%
MCRB Seres Therapeutics, Inc. Sell -3.12% 23.86%
The percentage of cash held in the portfolio is: 61.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Buy All 4.09%
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.7% 8.8%
BAX Baxter International Inc. Buy 16.4% -2.7%
OMCL Omnicell, Inc. Buy 16.94% 0.5%
TDOC Teladoc Health, Inc. Sell -7.43% 1.47%
SMTI Sanara MedTech Inc. Sell -4.22% -2.45%
MCRB Seres Therapeutics, Inc. Sell -3.39% 17.72%
The percentage of cash held in the portfolio is: 69%
New Assets Added
None
Assets Removed
Asset Action Perf %
QTRX Sell All -9.55%
Assets Rebalanced
None
2024-03-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.59% 8.73%
QTRX Quanterix Corporation Buy 9.68% -3.95%
BAX Baxter International Inc. Buy 16.32% -2.42%
OMCL Omnicell, Inc. Buy 16.63% -0.54%
TDOC Teladoc Health, Inc. Sell -7.19% 3.9%
SMTI Sanara MedTech Inc. Sell -4.14% -1.22%
MCRB Seres Therapeutics, Inc. Sell -3.26% 20.2%
The percentage of cash held in the portfolio is: 59.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAGE Buy All 17.15%
SAVA Buy All -10.84%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.37% 6.46%
QTRX Quanterix Corporation Buy 9.58% -5.31%
BAX Baxter International Inc. Buy 16.21% -3.37%
OMCL Omnicell, Inc. Buy 16.59% -1.15%
SAGE Sage Therapeutics, Inc. Sell -10.58% 16.76%
TDOC Teladoc Health, Inc. Sell -7.26% 3.32%
SMTI Sanara MedTech Inc. Sell -4.06% 1.03%
SAVA Cassava Sciences, Inc. Sell -4.4% -7.26%
MCRB Seres Therapeutics, Inc. Sell -3.08% 24.95%
The percentage of cash held in the portfolio is: 74.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All -5.93%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.19% 4.78%
QTRX Quanterix Corporation Buy 9.58% -5.42%
BAX Baxter International Inc. Buy 16.27% -3.21%
OMCL Omnicell, Inc. Buy 16.75% -0.36%
ABUS Arbutus Biopharma Corporation Buy 12.9% -2.96%
SAGE Sage Therapeutics, Inc. Sell -10.92% 14.18%
TDOC Teladoc Health, Inc. Sell -7.27% 3.32%
SMTI Sanara MedTech Inc. Sell -4.13% -0.57%
SAVA Cassava Sciences, Inc. Sell -4.41% -7.31%
MCRB Seres Therapeutics, Inc. Sell -3.2% 22.18%
The percentage of cash held in the portfolio is: 62.24%
New Assets Added
None
Assets Removed
Asset Action Perf %
BRKR Sell All 15.05%
RCM Sell All 21.04%
Assets Rebalanced
None
2024-03-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.45% 14.72%
RCM R1 RCM Inc. Buy 15.42% 22.38%
THC Tenet Healthcare Corporation Buy 12.25% 6.1%
QTRX Quanterix Corporation Buy 9.44% -6.02%
BAX Baxter International Inc. Buy 16.3% -2.26%
OMCL Omnicell, Inc. Buy 16.55% -0.72%
ABUS Arbutus Biopharma Corporation Buy 12.75% -3.33%
SAGE Sage Therapeutics, Inc. Sell -10.75% 14.87%
TDOC Teladoc Health, Inc. Sell -7.08% 5.12%
SMTI Sanara MedTech Inc. Sell -4.03% 1.17%
SAVA Cassava Sciences, Inc. Sell -4.25% -4.28%
MCRB Seres Therapeutics, Inc. Sell -3.07% 24.65%
The percentage of cash held in the portfolio is: 33.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -15.74%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.28% 15.83%
RCM R1 RCM Inc. Buy 15.49% 25.69%
THC Tenet Healthcare Corporation Buy 11.97% 6.01%
MRSN Mersana Therapeutics, Inc. Buy 10.72% -5.05%
QTRX Quanterix Corporation Buy 9.38% -4.49%
BAX Baxter International Inc. Buy 16.27% -0.23%
OMCL Omnicell, Inc. Buy 16.47% 1.04%
ABUS Arbutus Biopharma Corporation Buy 12.85% -0.37%
SAGE Sage Therapeutics, Inc. Sell -10.8% 12.55%
TDOC Teladoc Health, Inc. Sell -7.17% 1.73%
SMTI Sanara MedTech Inc. Sell -3.99% -0.16%
SAVA Cassava Sciences, Inc. Sell -4.18% -4.89%
MCRB Seres Therapeutics, Inc. Sell -3.05% 23.47%
The percentage of cash held in the portfolio is: 22.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Sell All -5.28%
Assets Rebalanced
None
2024-03-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.08% 13.88%
RCM R1 RCM Inc. Buy 15.35% 24.26%
THC Tenet Healthcare Corporation Buy 11.84% 4.66%
MRSN Mersana Therapeutics, Inc. Buy 11.01% -2.69%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.35% 0.33%
QTRX Quanterix Corporation Buy 9.31% -5.45%
BAX Baxter International Inc. Buy 16.64% 1.81%
OMCL Omnicell, Inc. Buy 16.79% 2.73%
ABUS Arbutus Biopharma Corporation Buy 13.07% 1.11%
SAGE Sage Therapeutics, Inc. Sell -11.75% 5.07%
TDOC Teladoc Health, Inc. Sell -7.21% 1.41%
SMTI Sanara MedTech Inc. Sell -3.96% 0.73%
SAVA Cassava Sciences, Inc. Sell -3.78% 5.34%
MCRB Seres Therapeutics, Inc. Sell -3.84% 3.86%
The percentage of cash held in the portfolio is: 12.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All -17.21%
Assets Rebalanced
None
2024-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 13.03% 15.17%
NUTX Nutex Health Inc. Buy 10.4% -13.11%
RCM R1 RCM Inc. Buy 15.45% 27.04%
THC Tenet Healthcare Corporation Buy 11.6% 4.1%
MRSN Mersana Therapeutics, Inc. Buy 10.98% -1.52%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.41% 2.41%
QTRX Quanterix Corporation Buy 9.69% -0.07%
BAX Baxter International Inc. Buy 16.28% 1.16%
OMCL Omnicell, Inc. Buy 16.25% 0.97%
ABUS Arbutus Biopharma Corporation Buy 12.73% 0%
SAGE Sage Therapeutics, Inc. Sell -11.19% 8.17%
TDOC Teladoc Health, Inc. Sell -7.07% 1.85%
SMTI Sanara MedTech Inc. Sell -3.94% -0.11%
SAVA Cassava Sciences, Inc. Sell -3.82% 2.97%
MCRB Seres Therapeutics, Inc. Sell -3.82% 2.97%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ABUS
Assets Removed
Asset Action Perf %
ATRI Sell All 18.86%
Assets Rebalanced
None
2024-03-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 12.32% 13.11%
BRKR Bruker Corporation Buy 12.98% 13.09%
NUTX Nutex Health Inc. Buy 10.65% -12.3%
RCM R1 RCM Inc. Buy 15.38% 24.71%
THC Tenet Healthcare Corporation Buy 11.67% 3.23%
MRSN Mersana Therapeutics, Inc. Buy 10.92% -3.37%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.53% 2.02%
QTRX Quanterix Corporation Buy 9.91% 0.75%
BAX Baxter International Inc. Buy 16.32% 0%
OMCL Omnicell, Inc. Buy 16.32% 0%
SAGE Sage Therapeutics, Inc. Sell -11.23% 9.2%
TDOC Teladoc Health, Inc. Sell -6.81% 6.78%
SMTI Sanara MedTech Inc. Sell -3.99% 0%
SAVA Cassava Sciences, Inc. Sell -3.99% 0%
MCRB Seres Therapeutics, Inc. Sell -3.99% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • SAVA
  • MCRB
  • BAX
  • OMCL
Assets Removed
Asset Action Perf %
TVTX Buy All -4.24%
NVTA Buy All 83.05%
Assets Rebalanced
None
2024-03-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 12.79% 17.92%
BRKR Bruker Corporation Buy 12.88% 12.64%
NUTX Nutex Health Inc. Buy 10.71% -11.48%
RCM R1 RCM Inc. Buy 15.37% 25.07%
THC Tenet Healthcare Corporation Buy 11.41% 1.35%
MRSN Mersana Therapeutics, Inc. Buy 10.94% -2.86%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.05% -1.89%
QTRX Quanterix Corporation Buy 9.85% 0.5%
TVTX Travere Therapeutics, Inc. Sell -5.47% 2.66%
NVTA Invitae Corporation Sell -0.98% 82.49%
SAGE Sage Therapeutics, Inc. Sell -11.24% 8.77%
TDOC Teladoc Health, Inc. Sell -6.69% 7.99%
The percentage of cash held in the portfolio is: 29.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
HAE Buy All -6.69%
NTLA Sell All 19.61%
RGNX Sell All 68.91%
Assets Rebalanced
None
2024-03-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 15.64% 28.07%
ATRI Atrion Corporation Buy 12.32% 11.54%
RGNX REGENXBIO Inc. Buy 15.62% 46.6%
BRKR Bruker Corporation Buy 13.09% 12.49%
NUTX Nutex Health Inc. Buy 11.51% -6.56%
RCM R1 RCM Inc. Buy 15.67% 25.25%
THC Tenet Healthcare Corporation Buy 11.39% -0.63%
MRSN Mersana Therapeutics, Inc. Buy 11.1% -3.2%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.69% 1.95%
QTRX Quanterix Corporation Buy 9.98% 0%
TVTX Travere Therapeutics, Inc. Sell -5.67% 0.85%
NVTA Invitae Corporation Sell -1.07% 81.37%
HAE Haemonetics Corporation Sell -5.09% -4.3%
SAGE Sage Therapeutics, Inc. Sell -11.73% 6.45%
TDOC Teladoc Health, Inc. Sell -6.98% 5.82%
The percentage of cash held in the portfolio is: 2.53%
New Assets Added
  • QTRX
Assets Removed
Asset Action Perf %
RVNC Sell All -14.99%
Assets Rebalanced
None
2024-03-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 15.73% 29.14%
ATRI Atrion Corporation Buy 11.35% 3.03%
RGNX REGENXBIO Inc. Buy 15.45% 45.44%
BRKR Bruker Corporation Buy 12.81% 10.34%
NUTX Nutex Health Inc. Buy 11.38% -7.38%
RCM R1 RCM Inc. Buy 15.64% 25.34%
RVNC Revance Therapeutics, Inc. Buy 11.35% -2.24%
THC Tenet Healthcare Corporation Buy 11.43% 0%
MRSN Mersana Therapeutics, Inc. Buy 11.43% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 11.43% 0%
TVTX Travere Therapeutics, Inc. Sell -5.43% 4.72%
NVTA Invitae Corporation Sell -1.31% 77.1%
HAE Haemonetics Corporation Sell -5.03% -3.43%
SAGE Sage Therapeutics, Inc. Sell -11.75% 6.06%
TDOC Teladoc Health, Inc. Sell -7.08% 4.09%
The percentage of cash held in the portfolio is: 2.6%
New Assets Added
  • THC
  • MRSN
  • ENTA
Assets Removed
None
Assets Rebalanced
None
2024-03-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 15.73% 27.01%
ATRI Atrion Corporation Buy 11.83% 5.65%
RGNX REGENXBIO Inc. Buy 12.93% 19.7%
BRKR Bruker Corporation Buy 12.76% 8.11%
NUTX Nutex Health Inc. Buy 11.57% -7.38%
RCM R1 RCM Inc. Buy 15.96% 25.78%
RVNC Revance Therapeutics, Inc. Buy 11.8% 0%
TVTX Travere Therapeutics, Inc. Sell -5.31% 8.47%
NVTA Invitae Corporation Sell -0.79% 86.42%
HAE Haemonetics Corporation Sell -5.04% -1.79%
SAGE Sage Therapeutics, Inc. Sell -11.74% 7.69%
TDOC Teladoc Health, Inc. Sell -7.24% 3.58%
The percentage of cash held in the portfolio is: 37.52%
New Assets Added
  • RVNC
Assets Removed
Asset Action Perf %
CARA Sell All 32.4%
NVAX Sell All 14.88%
VRDN Sell All -7.24%
Assets Rebalanced
None
2024-02-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 15.87% 29.7%
ATRI Atrion Corporation Buy 11.53% 4.21%
RGNX REGENXBIO Inc. Buy 14.57% 36.58%
BRKR Bruker Corporation Buy 12.59% 8.03%
NUTX Nutex Health Inc. Buy 11.32% -8.2%
NVAX Novavax, Inc. Buy 12.85% 2.56%
RCM R1 RCM Inc. Buy 16.14% 28.83%
CARA Cara Therapeutics, Inc. Buy 16.51% 38.63%
VRDN Viridian Therapeutics, Inc. Buy 8.31% 0%
TVTX Travere Therapeutics, Inc. Sell -5.4% 5.69%
NVTA Invitae Corporation Sell -0.71% 87.54%
HAE Haemonetics Corporation Sell -5.1% -4.42%
SAGE Sage Therapeutics, Inc. Sell -12.17% 3.09%
TDOC Teladoc Health, Inc. Sell -7.16% 3.52%
The percentage of cash held in the portfolio is: 10.85%
New Assets Added
  • VRDN
Assets Removed
Asset Action Perf %
CUTR Sell All -32.07%
INGN Sell All -38.03%
Assets Rebalanced
None
2024-02-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 13.41% 7.47%
ATRI Atrion Corporation Buy 11.02% -2.34%
RGNX REGENXBIO Inc. Buy 13.57% 24.71%
BRKR Bruker Corporation Buy 12.44% 4.61%
NUTX Nutex Health Inc. Buy 12.17% -3.28%
CUTR Cutera, Inc. Buy 11.2% -8.97%
NVAX Novavax, Inc. Buy 14.51% 13.49%
RCM R1 RCM Inc. Buy 12.75% -0.27%
INGN Inogen, Inc. Buy 11.8% -7.68%
CARA Cara Therapeutics, Inc. Buy 15.12% 24.45%
TVTX Travere Therapeutics, Inc. Sell -5.56% 4.84%
NVTA Invitae Corporation Sell -0.89% 84.85%
HAE Haemonetics Corporation Sell -5.21% -4.46%
SAGE Sage Therapeutics, Inc. Sell -12.25% 4.38%
TDOC Teladoc Health, Inc. Sell -7.36% 2.75%
The percentage of cash held in the portfolio is: 3.26%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
RGNX Buy 1.56%
2024-02-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 13.95% 6.29%
ATRI Atrion Corporation Buy 12.37% 4.18%
RGNX REGENXBIO Inc. Buy 12.8% 26.29%
NUTX Nutex Health Inc. Buy 12.8% -3.28%
CUTR Cutera, Inc. Buy 12.09% -6.55%
BRKR Bruker Corporation Buy 12.8% 2.34%
RCM R1 RCM Inc. Buy 12.85% -4.39%
NVAX Novavax, Inc. Buy 12.44% -7.44%
INGN Inogen, Inc. Buy 12.44% -7.49%
CARA Cara Therapeutics, Inc. Buy 13.45% 5.3%
TVTX Travere Therapeutics, Inc. Sell -5.86% 4.6%
NVTA Invitae Corporation Sell -1.03% 83.16%
HAE Haemonetics Corporation Sell -5.36% -2.19%
SAGE Sage Therapeutics, Inc. Sell -12.86% 4.6%
TDOC Teladoc Health, Inc. Sell -7.96% 0%
The percentage of cash held in the portfolio is: 5.07%
New Assets Added
  • TDOC
Assets Removed
Asset Action Perf %
EBS Buy All -64.24%
Assets Rebalanced
Asset Action Weight
CUTR Sell -1.57%
NUTX Sell -1.34%
RGNX Sell -1.96%
BRKR Sell -2.16%
NTLA Buy 1.95%
2024-02-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.57% 7.35%
ATRI Atrion Corporation Buy 11.58% 2.22%
RGNX REGENXBIO Inc. Buy 14.19% 27.25%
NUTX Nutex Health Inc. Buy 13.15% -5.74%
BRKR Bruker Corporation Buy 14.13% 1.31%
CUTR Cutera, Inc. Buy 14.1% 1.03%
RCM R1 RCM Inc. Buy 12.37% -3.58%
INGN Inogen, Inc. Buy 12% -6.5%
NVAX Novavax, Inc. Buy 12.32% -3.95%
CARA Cara Therapeutics, Inc. Buy 12.19% 0%
EBS Emergent BioSolutions Inc. Sell -5.38% 7.88%
TVTX Travere Therapeutics, Inc. Sell -5.88% -0.24%
NVTA Invitae Corporation Sell -1.11% 81.14%
HAE Haemonetics Corporation Sell -4.99% 0.38%
SAGE Sage Therapeutics, Inc. Sell -12.25% 4.73%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
Assets Removed
Asset Action Perf %
MRSN Sell All -14.18%
Assets Rebalanced
None
2024-02-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.61% 9.69%
ATRI Atrion Corporation Buy 11.25% 1.11%
RGNX REGENXBIO Inc. Buy 14.16% 29.24%
MRSN Mersana Therapeutics, Inc. Buy 12.62% -10.17%
NUTX Nutex Health Inc. Buy 13.7% 0%
BRKR Bruker Corporation Buy 14.01% 2.21%
CUTR Cutera, Inc. Buy 13.85% 1.03%
RCM R1 RCM Inc. Buy 12.27% -2.69%
INGN Inogen, Inc. Buy 12.46% -1.18%
NVAX Novavax, Inc. Buy 12.19% -3.26%
EBS Emergent BioSolutions Inc. Sell -5.43% 5.45%
TVTX Travere Therapeutics, Inc. Sell -5.72% 0.73%
NVTA Invitae Corporation Sell -1.26% 78.11%
HAE Haemonetics Corporation Sell -4.96% -0.92%
SAGE Sage Therapeutics, Inc. Sell -12.63% 0%
The percentage of cash held in the portfolio is: 1.89%
New Assets Added
  • SAGE
Assets Removed
Asset Action Perf %
CARA Buy All -20.38%
Assets Rebalanced
None
2024-02-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.84% 12.57%
ATRI Atrion Corporation Buy 11.23% 1.57%
RGNX REGENXBIO Inc. Buy 13.78% 26.63%
MRSN Mersana Therapeutics, Inc. Buy 12.67% -9.22%
NUTX Nutex Health Inc. Buy 13.51% -0.82%
BRKR Bruker Corporation Buy 13.63% 0.06%
CUTR Cutera, Inc. Buy 13.76% 1.03%
RCM R1 RCM Inc. Buy 12.53% 0%
INGN Inogen, Inc. Buy 12.53% 0%
NVAX Novavax, Inc. Buy 12.53% 0%
EBS Emergent BioSolutions Inc. Sell -5.88% -3.03%
TVTX Travere Therapeutics, Inc. Sell -6.06% -5.81%
NVTA Invitae Corporation Sell -1.18% 79.46%
CARA Cara Therapeutics, Inc. Sell -13.16% -14.42%
HAE Haemonetics Corporation Sell -4.9% -0.25%
The percentage of cash held in the portfolio is: 3.17%
New Assets Added
  • RCM
  • INGN
  • NVAX
Assets Removed
Asset Action Perf %
AGEN Sell All -7.14%
Assets Rebalanced
None
2024-02-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.33% 11.82%
AGEN Agenus Inc. Buy 15.72% 32.56%
ATRI Atrion Corporation Buy 10.27% -3.57%
RGNX REGENXBIO Inc. Buy 12.08% 15.24%
MRSN Mersana Therapeutics, Inc. Buy 12.05% -10.4%
NUTX Nutex Health Inc. Buy 13.12% 0%
BRKR Bruker Corporation Buy 13.12% 0%
CUTR Cutera, Inc. Buy 13.12% 0%
EBS Emergent BioSolutions Inc. Sell -5.63% -2.42%
TVTX Travere Therapeutics, Inc. Sell -5.51% 0.12%
NVTA Invitae Corporation Sell -1.18% 78.68%
CARA Cara Therapeutics, Inc. Sell -12.04% -8.65%
HAE Haemonetics Corporation Sell -4.68% 0.64%
The percentage of cash held in the portfolio is: 28.23%
New Assets Added
  • NUTX
  • BRKR
  • CUTR
Assets Removed
Asset Action Perf %
LXRX Sell All 55.87%
Assets Rebalanced
None
2024-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.14% 4.59%
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.88% 37.56%
AGEN Agenus Inc. Buy 13.53% 8.57%
ATRI Atrion Corporation Buy 10.96% -2.04%
RGNX REGENXBIO Inc. Buy 12.13% 10.09%
MRSN Mersana Therapeutics, Inc. Buy 12.79% -9.46%
EBS Emergent BioSolutions Inc. Sell -5.56% 3.64%
TVTX Travere Therapeutics, Inc. Sell -5.6% 3.27%
NVTA Invitae Corporation Sell -1.95% 66.33%
CARA Cara Therapeutics, Inc. Sell -11.94% -2.5%
HAE Haemonetics Corporation Sell -4.95% 0%
The percentage of cash held in the portfolio is: 57.57%
New Assets Added
  • HAE
Assets Removed
Asset Action Perf %
ARCT Sell All 2.7%
SAVA Sell All -6.26%
SMTI Sell All -9.09%
CLDX Sell All -6.72%
Assets Rebalanced
None
2024-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.83% 17.08%
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.23% 37.09%
ARCT Arcturus Therapeutics Holdings Inc. Buy 13.03% 10.25%
AGEN Agenus Inc. Buy 13.68% 15.71%
ATRI Atrion Corporation Buy 11.87% 11.82%
CLDX Celldex Therapeutics, Inc. Buy 11.99% -0.58%
SMTI Sanara MedTech Inc. Buy 11.84% -1.84%
SAVA Cassava Sciences, Inc. Buy 13.53% -1.93%
RGNX REGENXBIO Inc. Buy 12.45% 19.15%
MRSN Mersana Therapeutics, Inc. Buy 12.45% -7.09%
EBS Emergent BioSolutions Inc. Sell -5.97% -9.09%
TVTX Travere Therapeutics, Inc. Sell -5.89% -7.26%
NVTA Invitae Corporation Sell -2.28% 58.47%
CARA Cara Therapeutics, Inc. Sell -12.39% -12.12%
The percentage of cash held in the portfolio is: 2.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Buy All -27.2%
Assets Rebalanced
Asset Action Weight
ATRI Sell -1.35%
LXRX Sell -2.62%
RGNX Sell -1.92%
MRSN Sell -3.49%
SAVA Buy 0.63%
2024-02-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.15% 7.98%
NTLA Intellia Therapeutics, Inc. Buy 11.21% 8.62%
ATRI Atrion Corporation Buy 12.78% 5.75%
ARCT Arcturus Therapeutics Holdings Inc. Buy 12.14% 0.42%
AGEN Agenus Inc. Buy 12.08% 0%
SMTI Sanara MedTech Inc. Buy 12.83% 4.06%
RGNX REGENXBIO Inc. Buy 13.78% 11.81%
CLDX Celldex Therapeutics, Inc. Buy 12.23% -0.77%
SAVA Cassava Sciences, Inc. Buy 12.26% -0.59%
MRSN Mersana Therapeutics, Inc. Buy 17.54% 0%
EBS Emergent BioSolutions Inc. Sell -5.7% -1.82%
CUTR Cutera, Inc. Sell -6.23% -10.88%
TVTX Travere Therapeutics, Inc. Sell -5.64% -0.48%
NVTA Invitae Corporation Sell -1.13% 79.8%
CARA Cara Therapeutics, Inc. Sell -11.29% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
  • MRSN
Assets Removed
Asset Action Perf %
PAHC Buy All -7.81%
Assets Rebalanced
None
2024-02-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.79% 0.94%
NTLA Intellia Therapeutics, Inc. Buy 11.01% 3.08%
ATRI Atrion Corporation Buy 13.21% 5.59%
ARCT Arcturus Therapeutics Holdings Inc. Buy 12.36% -1.19%
AGEN Agenus Inc. Buy 12.15% -2.86%
SMTI Sanara MedTech Inc. Buy 12.76% 0%
RGNX REGENXBIO Inc. Buy 12.76% 0%
CLDX Celldex Therapeutics, Inc. Buy 12.76% 0%
SAVA Cassava Sciences, Inc. Buy 12.76% 0%
EBS Emergent BioSolutions Inc. Sell -5.27% 9.09%
PAHC Phibro Animal Health Corporation Sell -5.8% -0.38%
CUTR Cutera, Inc. Sell -6.79% -16.74%
TVTX Travere Therapeutics, Inc. Sell -5.83% -0.24%
NVTA Invitae Corporation Sell -1.63% 71.94%
The percentage of cash held in the portfolio is: 14.76%
New Assets Added
  • SMTI
  • RGNX
  • CLDX
  • SAVA
Assets Removed
None
Assets Rebalanced
None
2024-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.6% 3.76%
NTLA Intellia Therapeutics, Inc. Buy 11.74% 5.06%
ATRI Atrion Corporation Buy 13.08% 0%
ARCT Arcturus Therapeutics Holdings Inc. Buy 13.08% 0%
AGEN Agenus Inc. Buy 13.08% 0%
EBS Emergent BioSolutions Inc. Sell -5.73% 5.45%
PAHC Phibro Animal Health Corporation Sell -6.15% -1.79%
CUTR Cutera, Inc. Sell -7.07% -16.32%
TVTX Travere Therapeutics, Inc. Sell -6.38% -4.96%
NVTA Invitae Corporation Sell -6.07% 0.11%
The percentage of cash held in the portfolio is: 68.82%
New Assets Added
  • ATRI
  • ARCT
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.77% -3.76%
NTLA Intellia Therapeutics, Inc. Buy 10.99% -1.78%
EBS Emergent BioSolutions Inc. Sell -5.63% 7.27%
PAHC Phibro Animal Health Corporation Sell -6.1% -0.85%
CUTR Cutera, Inc. Sell -6.09% 0%
TVTX Travere Therapeutics, Inc. Sell -6.09% 0%
NVTA Invitae Corporation Sell -6.09% 0%
The percentage of cash held in the portfolio is: 108.23%
New Assets Added
  • CUTR
  • TVTX
  • NVTA
Assets Removed
Asset Action Perf %
PTGX Sell All -8.8%
Assets Rebalanced
None
2024-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 9.72% -7.12%
LXRX Lexicon Pharmaceuticals, Inc. Buy 11.14% 0%
NTLA Intellia Therapeutics, Inc. Buy 11.14% 0%
EBS Emergent BioSolutions Inc. Sell -5.93% 1.82%
PAHC Phibro Animal Health Corporation Sell -6.02% 0%
The percentage of cash held in the portfolio is: 79.95%
New Assets Added
  • PAHC
  • LXRX
  • NTLA
Assets Removed
None
Assets Rebalanced
None
2024-02-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 10.4% 0%
EBS Emergent BioSolutions Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 95.6%
New Assets Added
  • EBS
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2023-12-20 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 7.75%
Assets Rebalanced
None
2023-12-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
STAA STAAR Surgical Company Sell -5.68% 4.08%
The percentage of cash held in the portfolio is: 105.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
HCSG Sell All -1.67%
Assets Rebalanced
None
2023-12-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 5.52% -0.59%
STAA STAAR Surgical Company Sell -6.02% -1.38%
The percentage of cash held in the portfolio is: 100.5%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Sell All 31.73%
SGRY Sell All 17.23%
AMEH Sell All 8.26%
NVCR Sell All 6.02%
Assets Rebalanced
None
2023-12-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 11.8% 27.01%
SGRY Surgery Partners, Inc. Buy 13.06% 13.65%
AMEH Apollo Medical Holdings, Inc. Buy 11.29% 3.72%
NVCR NovoCure Limited Buy 11.71% 3.28%
HCSG Healthcare Services Group, Inc. Buy 5.64% 0.29%
STAA STAAR Surgical Company Sell -5.81% 3.39%
The percentage of cash held in the portfolio is: 52.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
CBAY Sell All 26.67%
SENS Sell All 13.51%
Assets Rebalanced
None
2023-12-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CBAY CymaBay Therapeutics, Inc. Buy 14.25% 29.05%
SENS Senseonics Holdings, Inc. Buy 12.5% 13.15%
THC Tenet Healthcare Corporation Buy 11.18% 17.93%
SGRY Surgery Partners, Inc. Buy 12.63% 7.62%
AMEH Apollo Medical Holdings, Inc. Buy 10.84% -2.46%
NVCR NovoCure Limited Buy 11.65% 0.62%
HCSG Healthcare Services Group, Inc. Buy 5.59% -2.65%
STAA STAAR Surgical Company Sell -5.52% 10.08%
The percentage of cash held in the portfolio is: 26.89%
New Assets Added
None
Assets Removed
Asset Action Perf %
BMRN Sell All 11.05%
Assets Rebalanced
None
2023-12-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 14.06% 10.14%
CBAY CymaBay Therapeutics, Inc. Buy 13.73% 23.65%
SENS Senseonics Holdings, Inc. Buy 12.35% 11.17%
THC Tenet Healthcare Corporation Buy 11.33% 18.82%
SGRY Surgery Partners, Inc. Buy 12.86% 8.95%
AMEH Apollo Medical Holdings, Inc. Buy 10.97% -1.85%
NVCR NovoCure Limited Buy 11.71% 0.55%
HCSG Healthcare Services Group, Inc. Buy 5.55% -3.83%
STAA STAAR Surgical Company Sell -5.43% 12.14%
The percentage of cash held in the portfolio is: 12.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
MNKD Buy All 2.45%
Assets Rebalanced
None
2023-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 13.78% 10.42%
CBAY CymaBay Therapeutics, Inc. Buy 13.11% 20.69%
SENS Senseonics Holdings, Inc. Buy 12.9% 18.74%
THC Tenet Healthcare Corporation Buy 11.53% 23.69%
SGRY Surgery Partners, Inc. Buy 13.58% 17.66%
AMEH Apollo Medical Holdings, Inc. Buy 11.17% 2.23%
NVCR NovoCure Limited Buy 11.56% 1.48%
HCSG Healthcare Services Group, Inc. Buy 5.59% -0.98%
MNKD MannKind Corporation Sell -4.74% -1.9%
STAA STAAR Surgical Company Sell -5.6% 7.29%
The percentage of cash held in the portfolio is: 17.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMN Buy All -8.62%
Assets Rebalanced
None
2023-12-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 13.81% 8.11%
CBAY CymaBay Therapeutics, Inc. Buy 12.99% 16.83%
SENS Senseonics Holdings, Inc. Buy 12.8% 15.14%
THC Tenet Healthcare Corporation Buy 11.59% 21.47%
SGRY Surgery Partners, Inc. Buy 13.33% 12.82%
AMEH Apollo Medical Holdings, Inc. Buy 11.4% 1.99%
NVCR NovoCure Limited Buy 11.38% -2.34%
HCSG Healthcare Services Group, Inc. Buy 5.67% -1.86%
AMN AMN Healthcare Services, Inc. Sell -4.6% -3.07%
MNKD MannKind Corporation Sell -4.87% -2.45%
STAA STAAR Surgical Company Sell -5.85% 5.28%
The percentage of cash held in the portfolio is: 22.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGIO Buy All -8.33%
EW Sell All 7.1%
ISRG Sell All 13.43%
Assets Rebalanced
None
2023-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 13.75% 4.81%
ISRG Intuitive Surgical, Inc. Buy 14.38% 9.86%
BMRN BioMarin Pharmaceutical Inc. Buy 13.8% 2.37%
CBAY CymaBay Therapeutics, Inc. Buy 12.76% 8.83%
SENS Senseonics Holdings, Inc. Buy 12.43% 5.95%
THC Tenet Healthcare Corporation Buy 10.98% 9.03%
SGRY Surgery Partners, Inc. Buy 13.32% 6.83%
AMEH Apollo Medical Holdings, Inc. Buy 12.15% 2.96%
NVCR NovoCure Limited Buy 11.88% -3.36%
HCSG Healthcare Services Group, Inc. Buy 6.03% -1.18%
AMN AMN Healthcare Services, Inc. Sell -4.67% 0.76%
MNKD MannKind Corporation Sell -5.18% -3.26%
AGIO Agios Pharmaceuticals, Inc. Sell -7.1% -5.3%
STAA STAAR Surgical Company Sell -6.52% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • STAA
Assets Removed
None
Assets Rebalanced
Asset Action Weight
SGRY Buy 1.39%
AMEH Buy 1.78%
NVCR Buy 2.15%
2023-11-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 14% 4.98%
ISRG Intuitive Surgical, Inc. Buy 14.05% 5.52%
BMRN BioMarin Pharmaceutical Inc. Buy 13.96% 1.84%
CBAY CymaBay Therapeutics, Inc. Buy 12.72% 6.7%
SENS Senseonics Holdings, Inc. Buy 13.02% 9.19%
NVCR NovoCure Limited Buy 10.14% -0.94%
THC Tenet Healthcare Corporation Buy 10.27% 0.33%
SGRY Surgery Partners, Inc. Buy 10.55% 2.98%
AMEH Apollo Medical Holdings, Inc. Buy 10.28% 0.41%
HCSG Healthcare Services Group, Inc. Buy 6.2% 0%
AMN AMN Healthcare Services, Inc. Sell -4.71% 1.61%
MNKD MannKind Corporation Sell -5.2% -1.9%
AGIO Agios Pharmaceuticals, Inc. Sell -7.29% -6.29%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
VTRS Buy All -4.58%
PODD Sell All 27.65%
Assets Rebalanced
None
2023-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 13.82% 27.25%
EW Edwards Lifesciences Corporation Buy 14% 3.07%
ISRG Intuitive Surgical, Inc. Buy 14.22% 4.94%
BMRN BioMarin Pharmaceutical Inc. Buy 13.85% -0.74%
CBAY CymaBay Therapeutics, Inc. Buy 12.38% 1.96%
SENS Senseonics Holdings, Inc. Buy 12.65% 4.22%
NVCR NovoCure Limited Buy 10.42% 0%
THC Tenet Healthcare Corporation Buy 10.42% 0%
SGRY Surgery Partners, Inc. Buy 10.42% 0%
AMEH Apollo Medical Holdings, Inc. Buy 10.42% 0%
AMN AMN Healthcare Services, Inc. Sell -4.59% 5.76%
MNKD MannKind Corporation Sell -5.25% -1.09%
AGIO Agios Pharmaceuticals, Inc. Sell -7.36% -5.49%
VTRS Viatris Inc. Sell -7.4% -3.02%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
  • THC
  • SGRY
  • AMEH
Assets Removed
Asset Action Perf %
XNCR Buy All -11.68%
Assets Rebalanced
None
2023-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 13.18% 20.45%
EW Edwards Lifesciences Corporation Buy 13.85% 1.21%
ISRG Intuitive Surgical, Inc. Buy 13.88% 1.65%
BMRN BioMarin Pharmaceutical Inc. Buy 13.71% -2.46%
CBAY CymaBay Therapeutics, Inc. Buy 12.23% 0%
SENS Senseonics Holdings, Inc. Buy 12.23% 0%
AMN AMN Healthcare Services, Inc. Sell -4.25% 13.37%
MNKD MannKind Corporation Sell -5.04% 3.8%
XNCR Xencor, Inc. Sell -6.37% -3.15%
AGIO Agios Pharmaceuticals, Inc. Sell -7.1% -0.95%
VTRS Viatris Inc. Sell -7.24% 0%
The percentage of cash held in the portfolio is: 50.92%
New Assets Added
  • VTRS
  • CBAY
  • SENS
Assets Removed
None
Assets Rebalanced
None
2023-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 12.6% 14.12%
EW Edwards Lifesciences Corporation Buy 13.88% 0.6%
ISRG Intuitive Surgical, Inc. Buy 13.75% -0.14%
BMRN BioMarin Pharmaceutical Inc. Buy 13.93% -1.77%
AMN AMN Healthcare Services, Inc. Sell -4.46% 9.99%
MNKD MannKind Corporation Sell -4.92% 6.79%
XNCR Xencor, Inc. Sell -6.43% -3.21%
AGIO Agios Pharmaceuticals, Inc. Sell -7.09% 0%
The percentage of cash held in the portfolio is: 68.74%
New Assets Added
  • AGIO
Assets Removed
Asset Action Perf %
ABUS Buy All 3.8%
PCRX Buy All 3.13%
MODV Sell All 22.73%
Assets Rebalanced
None
2023-11-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 12.8% 21.26%
PODD Insulet Corporation Buy 12.48% 12.49%
EW Edwards Lifesciences Corporation Buy 14.05% 1.28%
ISRG Intuitive Surgical, Inc. Buy 13.57% -1.98%
BMRN BioMarin Pharmaceutical Inc. Buy 13.96% -2.07%
ABUS Arbutus Biopharma Corporation Sell -7.16% 2.17%
PCRX Pacira BioSciences, Inc. Sell -7.08% 3.3%
AMN AMN Healthcare Services, Inc. Sell -4.49% 9.8%
MNKD MannKind Corporation Sell -5.01% 5.71%
XNCR Xencor, Inc. Sell -6.26% 0%
The percentage of cash held in the portfolio is: 63.14%
New Assets Added
  • XNCR
Assets Removed
Asset Action Perf %
VEEV Buy All 19.88%
EDIT Sell All 14.06%
VNDA Sell All -22.65%
Assets Rebalanced
None
2023-11-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 13.47% 33.08%
PODD Insulet Corporation Buy 12.13% 14.02%
VNDA Vanda Pharmaceuticals Inc. Buy 13.05% -0.92%
EDIT Editas Medicine, Inc. Buy 12.86% 21.74%
EW Edwards Lifesciences Corporation Buy 13.8% 3.78%
ISRG Intuitive Surgical, Inc. Buy 13.28% 0.01%
BMRN BioMarin Pharmaceutical Inc. Buy 13.67% 0.02%
ABUS Arbutus Biopharma Corporation Sell -7.13% -1.63%
PCRX Pacira BioSciences, Inc. Sell -7.14% -1.77%
VEEV Veeva Systems Inc. Sell -6.65% 6.64%
AMN AMN Healthcare Services, Inc. Sell -4.3% 9.93%
MNKD MannKind Corporation Sell -5.05% 0.82%
The percentage of cash held in the portfolio is: 38.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -4.54%
SMMT Sell All -6.41%
Assets Rebalanced
None
2023-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 13.2% 34.75%
PODD Insulet Corporation Buy 12.26% 19.1%
VNDA Vanda Pharmaceuticals Inc. Buy 12.92% 1.37%
SMMT Summit Therapeutics Inc. Buy 11.2% -1.79%
EDIT Editas Medicine, Inc. Buy 13.28% 29.86%
EW Edwards Lifesciences Corporation Buy 13.42% 4.23%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.08% 5.93%
ISRG Intuitive Surgical, Inc. Buy 12.88% 0.29%
BMRN BioMarin Pharmaceutical Inc. Buy 13.22% 0%
ABUS Arbutus Biopharma Corporation Sell -6.83% -0.54%
PCRX Pacira BioSciences, Inc. Sell -7% -2.99%
VEEV Veeva Systems Inc. Sell -6.43% 6.65%
AMN AMN Healthcare Services, Inc. Sell -4.33% 6.31%
MNKD MannKind Corporation Sell -5.09% -3.26%
The percentage of cash held in the portfolio is: 15.22%
New Assets Added
  • BMRN
Assets Removed
Asset Action Perf %
VRTX Sell All 4.89%
CYTK Sell All 17.16%
Assets Rebalanced
None
2023-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 12.64% 6.97%
CYTK Cytokinetics, Incorporated Buy 13.53% 12.52%
MODV ModivCare Inc. Buy 13.47% 37.32%
PODD Insulet Corporation Buy 12.05% 16.93%
VNDA Vanda Pharmaceuticals Inc. Buy 13.02% 2.06%
SMMT Summit Therapeutics Inc. Buy 12.76% 11.79%
EDIT Editas Medicine, Inc. Buy 12.33% 20.43%
EW Edwards Lifesciences Corporation Buy 13.55% 5.12%
BCRX BioCryst Pharmaceuticals, Inc. Buy 11.81% 3.49%
ISRG Intuitive Surgical, Inc. Buy 12.83% -0.23%
ABUS Arbutus Biopharma Corporation Sell -6.95% -2.17%
PCRX Pacira BioSciences, Inc. Sell -7.11% -4.56%
VEEV Veeva Systems Inc. Sell -6.51% 5.67%
AMN AMN Healthcare Services, Inc. Sell -4.5% 2.68%
MNKD MannKind Corporation Sell -4.93% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MNKD
Assets Removed
None
Assets Rebalanced
Asset Action Weight
MODV Buy 0.65%
EW Buy 0.8%
CYTK Buy 2.07%
2023-11-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYTK Cytokinetics, Incorporated Buy 12.1% 18.69%
VRTX Vertex Pharmaceuticals Incorporated Buy 12.34% 4.32%
MODV ModivCare Inc. Buy 12.34% 39.34%
PODD Insulet Corporation Buy 12.34% 19.62%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.04% 5.41%
EW Edwards Lifesciences Corporation Buy 12% 5.08%
VNDA Vanda Pharmaceuticals Inc. Buy 13.21% 3.43%
SMMT Summit Therapeutics Inc. Buy 11.77% 3.08%
EDIT Editas Medicine, Inc. Buy 12.34% 20.43%
ISRG Intuitive Surgical, Inc. Buy 12.9% 0.23%
ABUS Arbutus Biopharma Corporation Sell -7.1% -4.35%
PCRX Pacira BioSciences, Inc. Sell -7.19% -5.58%
VEEV Veeva Systems Inc. Sell -6.46% 6.42%
AMN AMN Healthcare Services, Inc. Sell -4.63% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMN
Assets Removed
Asset Action Perf %
IRMD Buy All -11.09%
Assets Rebalanced
Asset Action Weight
EDIT Sell -1.42%
PODD Sell -2.82%
MODV Sell -2.98%
VNDA Buy 0.52%
ISRG Buy 0.92%
VRTX Buy 1.7%
2023-11-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 11.31% 4.42%
CYTK Cytokinetics, Incorporated Buy 12.26% 13.2%
MODV ModivCare Inc. Buy 14.66% 25.5%
PODD Insulet Corporation Buy 13.91% 3.33%
EW Edwards Lifesciences Corporation Buy 12.46% 2.66%
BCRX BioCryst Pharmaceuticals, Inc. Buy 11.95% -1.57%
EDIT Editas Medicine, Inc. Buy 12.37% 1.88%
SMMT Summit Therapeutics Inc. Buy 12.45% 2.56%
VNDA Vanda Pharmaceuticals Inc. Buy 12.42% 2.29%
ISRG Intuitive Surgical, Inc. Buy 12.11% 0%
IRMD IRadimed Corporation Sell -6.92% -1.08%
ABUS Arbutus Biopharma Corporation Sell -7.11% 1.63%
PCRX Pacira BioSciences, Inc. Sell -7.18% 0.71%
VEEV Veeva Systems Inc. Sell -6.7% 8.67%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ISRG
Assets Removed
None
Assets Rebalanced
None
2023-11-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 11.27% 2.42%
CYTK Cytokinetics, Incorporated Buy 12.62% 14.71%
MODV ModivCare Inc. Buy 14.44% 21.73%
PODD Insulet Corporation Buy 13.86% 1.33%
EW Edwards Lifesciences Corporation Buy 12.33% 0%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.33% 0%
EDIT Editas Medicine, Inc. Buy 12.33% 0%
SMMT Summit Therapeutics Inc. Buy 12.33% 0%
VNDA Vanda Pharmaceuticals Inc. Buy 12.33% 0%
IRMD IRadimed Corporation Sell -7.04% -1.23%
ABUS Arbutus Biopharma Corporation Sell -7.34% 0%
PCRX Pacira BioSciences, Inc. Sell -7.07% 3.71%
VEEV Veeva Systems Inc. Sell -6.7% 10.05%
The percentage of cash held in the portfolio is: 14.33%
New Assets Added
  • EW
  • BCRX
  • EDIT
  • SMMT
  • VNDA
Assets Removed
None
Assets Rebalanced
None
2023-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 11.13% 0.41%
CYTK Cytokinetics, Incorporated Buy 12.62% 13.92%
MODV ModivCare Inc. Buy 14.76% 23.54%
PODD Insulet Corporation Buy 13.43% -2.46%
IRMD IRadimed Corporation Sell -7.03% -0.44%
ABUS Arbutus Biopharma Corporation Sell -7.36% 0.54%
PCRX Pacira BioSciences, Inc. Sell -7.11% 3.88%
VEEV Veeva Systems Inc. Sell -6.95% 7.32%
The percentage of cash held in the portfolio is: 76.51%
New Assets Added
None
Assets Removed
Asset Action Perf %
RARE Buy All -11.57%
Assets Rebalanced
None
2023-10-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 11.19% 0.18%
CYTK Cytokinetics, Incorporated Buy 11.83% 5.92%
MODV ModivCare Inc. Buy 13.82% 14.74%
PODD Insulet Corporation Buy 13.8% -0.57%
IRMD IRadimed Corporation Sell -6.91% 2.12%
ABUS Arbutus Biopharma Corporation Sell -7.13% 4.35%
PCRX Pacira BioSciences, Inc. Sell -6.92% 7.18%
VEEV Veeva Systems Inc. Sell -6.91% 8.56%
RARE Ultragenyx Pharmaceutical Inc. Sell -5.22% -8.76%
The percentage of cash held in the portfolio is: 82.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMRX Sell All -4.25%
MYGN Sell All -8.91%
Assets Rebalanced
None
2023-10-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 11.03% 0.67%
CYTK Cytokinetics, Incorporated Buy 11.67% 6.5%
MODV ModivCare Inc. Buy 13.79% 16.64%
PODD Insulet Corporation Buy 13.99% 2.74%
AMRX Amneal Pharmaceuticals, Inc. Buy 13.32% -2%
MYGN Myriad Genetics, Inc. Buy 12.8% -5.83%
IRMD IRadimed Corporation Sell -6.66% 3.87%
ABUS Arbutus Biopharma Corporation Sell -6.88% 5.98%
PCRX Pacira BioSciences, Inc. Sell -6.78% 7.35%
VEEV Veeva Systems Inc. Sell -6.95% 6.33%
RARE Ultragenyx Pharmaceutical Inc. Sell -4.88% -3.47%
The percentage of cash held in the portfolio is: 55.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -22.92%
HAE Sell All -6.51%
STAA Sell All -11.44%
Assets Rebalanced
None
2023-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.59% 2.43%
CYTK Cytokinetics, Incorporated Buy 10.77% 4.12%
MODV ModivCare Inc. Buy 14.12% 26.62%
MRSN Mersana Therapeutics, Inc. Buy 12.98% -7.99%
PODD Insulet Corporation Buy 13.33% 3.75%
HAE Haemonetics Corporation Buy 13.77% -3.36%
STAA STAAR Surgical Company Buy 13.95% -2.08%
AMRX Amneal Pharmaceuticals, Inc. Buy 12.83% 0%
MYGN Myriad Genetics, Inc. Buy 12.83% 0%
IRMD IRadimed Corporation Sell -6.33% 3.16%
ABUS Arbutus Biopharma Corporation Sell -6.64% 3.8%
PCRX Pacira BioSciences, Inc. Sell -6.63% 4.01%
VEEV Veeva Systems Inc. Sell -6.64% 5.17%
RARE Ultragenyx Pharmaceutical Inc. Sell -4.51% -1.42%
The percentage of cash held in the portfolio is: 15.57%
New Assets Added
  • AMRX
  • MYGN
Assets Removed
None
Assets Rebalanced
None
2023-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.41% 1.95%
CYTK Cytokinetics, Incorporated Buy 10.63% 4.18%
MODV ModivCare Inc. Buy 13.16% 19.57%
MRSN Mersana Therapeutics, Inc. Buy 14.03% 0.69%
PODD Insulet Corporation Buy 13.72% 8.16%
HAE Haemonetics Corporation Buy 13.73% -2.4%
STAA STAAR Surgical Company Buy 13.35% -5.09%
IRMD IRadimed Corporation Sell -6.05% 6.11%
ABUS Arbutus Biopharma Corporation Sell -6.26% 8.15%
PCRX Pacira BioSciences, Inc. Sell -6.49% 4.73%
VEEV Veeva Systems Inc. Sell -6.49% 6.16%
RARE Ultragenyx Pharmaceutical Inc. Sell -4.43% -0.85%
The percentage of cash held in the portfolio is: 40.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All -9.98%
ENTA Sell All -9.78%
Assets Rebalanced
None
2023-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.12% 0.34%
CYTK Cytokinetics, Incorporated Buy 10.92% 8.2%
MODV ModivCare Inc. Buy 13.32% 22.4%
MRSN Mersana Therapeutics, Inc. Buy 14.53% 5.56%
PODD Insulet Corporation Buy 13.35% 6.49%
NVCR NovoCure Limited Buy 12.95% -6.85%
HAE Haemonetics Corporation Buy 13.62% -2.01%
STAA STAAR Surgical Company Buy 13.25% -4.71%
ENTA Enanta Pharmaceuticals, Inc. Buy 12.9% -7.26%
IRMD IRadimed Corporation Sell -6.11% 4.09%
ABUS Arbutus Biopharma Corporation Sell -6.37% 5.43%
PCRX Pacira BioSciences, Inc. Sell -6.53% 3.03%
VEEV Veeva Systems Inc. Sell -6.58% 3.63%
RARE Ultragenyx Pharmaceutical Inc. Sell -4.53% -4.38%
The percentage of cash held in the portfolio is: 15.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Sell All -9.35%
Assets Rebalanced
None
2023-10-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.12% 1.92%
CYTK Cytokinetics, Incorporated Buy 11.13% 12.09%
MODV ModivCare Inc. Buy 12.57% 17.46%
MRSN Mersana Therapeutics, Inc. Buy 13.88% 2.43%
PODD Insulet Corporation Buy 13.15% 6.59%
NVCR NovoCure Limited Buy 13.35% -2.43%
HAE Haemonetics Corporation Buy 13.66% -0.12%
STAA STAAR Surgical Company Buy 13.31% -2.72%
INGN Inogen, Inc. Buy 13.01% -4.88%
ENTA Enanta Pharmaceuticals, Inc. Buy 13.31% -2.72%
IRMD IRadimed Corporation Sell -6.03% 3.9%
ABUS Arbutus Biopharma Corporation Sell -6.41% 3.26%
PCRX Pacira BioSciences, Inc. Sell -6.63% 0%
VEEV Veeva Systems Inc. Sell -6.67% 0.84%
RARE Ultragenyx Pharmaceutical Inc. Sell -4.27% 0%
The percentage of cash held in the portfolio is: 2.52%
New Assets Added
  • RARE
Assets Removed
Asset Action Perf %
AVXL Buy All 20.76%
Assets Rebalanced
None
2023-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.16% 3.57%
CYTK Cytokinetics, Incorporated Buy 11.35% 15.62%
MODV ModivCare Inc. Buy 12.03% 13.63%
MRSN Mersana Therapeutics, Inc. Buy 14.14% 5.56%
PODD Insulet Corporation Buy 12.69% 4.02%
NVCR NovoCure Limited Buy 13.53% 0%
HAE Haemonetics Corporation Buy 13.53% 0%
STAA STAAR Surgical Company Buy 13.53% 0%
INGN Inogen, Inc. Buy 13.53% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 13.53% 0%
AVXL Anavex Life Sciences Corp. Sell -3.96% 15.99%
IRMD IRadimed Corporation Sell -6.01% 3.06%
ABUS Arbutus Biopharma Corporation Sell -6.73% -2.72%
PCRX Pacira BioSciences, Inc. Sell -6.65% -1.56%
VEEV Veeva Systems Inc. Sell -6.65% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VEEV
  • NVCR
  • HAE
  • STAA
  • INGN
  • ENTA
Assets Removed
None
Assets Rebalanced
None
2023-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.18% 3.71%
CYTK Cytokinetics, Incorporated Buy 11.12% 13.24%
MODV ModivCare Inc. Buy 11.34% 7.11%
MRSN Mersana Therapeutics, Inc. Buy 15.45% 15.28%
PODD Insulet Corporation Buy 12.2% 0%
AVXL Anavex Life Sciences Corp. Sell -4.01% 15.01%
IRMD IRadimed Corporation Sell -5.96% 3.99%
ABUS Arbutus Biopharma Corporation Sell -6.73% -2.72%
PCRX Pacira BioSciences, Inc. Sell -6.61% -0.82%
The percentage of cash held in the portfolio is: 63.01%
New Assets Added
  • PODD
Assets Removed
Asset Action Perf %
VCEL Buy All -8.78%
Assets Rebalanced
None
2023-10-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.27% 2.05%
CYTK Cytokinetics, Incorporated Buy 10.98% 9.12%
MODV ModivCare Inc. Buy 10.59% -2.43%
MRSN Mersana Therapeutics, Inc. Buy 13.74% 0%
AVXL Anavex Life Sciences Corp. Sell -3.99% 17.39%
IRMD IRadimed Corporation Sell -5.85% 8.01%
VCEL Vericel Corporation Sell -6.72% 0%
ABUS Arbutus Biopharma Corporation Sell -6.72% 0%
PCRX Pacira BioSciences, Inc. Sell -6.72% 0%
The percentage of cash held in the portfolio is: 84.42%
New Assets Added
  • VCEL
  • ABUS
  • PCRX
  • MRSN
Assets Removed
None
Assets Rebalanced
None
2023-10-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.14% 1.28%
CYTK Cytokinetics, Incorporated Buy 11.76% 17.48%
MODV ModivCare Inc. Buy 10.79% 0%
AVXL Anavex Life Sciences Corp. Sell -4.17% 13.18%
IRMD IRadimed Corporation Sell -6.09% 3.77%
The percentage of cash held in the portfolio is: 77.56%
New Assets Added
  • MODV
Assets Removed
None
Assets Rebalanced
None
2023-10-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.05% -1.5%
CYTK Cytokinetics, Incorporated Buy 10.57% 3.59%
AVXL Anavex Life Sciences Corp. Sell -4.22% 13.88%
IRMD IRadimed Corporation Sell -6.45% 0%
The percentage of cash held in the portfolio is: 90.05%
New Assets Added
  • IRMD
Assets Removed
None
Assets Rebalanced
None
2023-10-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.22% 0%
CYTK Cytokinetics, Incorporated Buy 10.22% 0%
AVXL Anavex Life Sciences Corp. Sell -4.23% 13.88%
The percentage of cash held in the portfolio is: 83.78%
New Assets Added
  • VRTX
  • CYTK
Assets Removed
Asset Action Perf %
BIO Buy All 3.57%
AGEN Buy All 15.87%
HQY Sell All 7.6%
CNC Sell All 5.67%
Assets Rebalanced
None
2023-10-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 16.85% 4.76%
CNC Centene Corporation Buy 16.8% 3.88%
BIO Bio-Rad Laboratories, Inc. Sell -6.32% 3.99%
AGEN Agenus Inc. Sell -5.61% 16.67%
AVXL Anavex Life Sciences Corp. Sell -4.45% 10.1%
The percentage of cash held in the portfolio is: 82.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
AORT Buy All 6.92%
Assets Rebalanced
None
2023-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 17.1% 6.42%
CNC Centene Corporation Buy 16.85% 4.3%
AORT Artivion, Inc. Sell -6.5% 1.62%
BIO Bio-Rad Laboratories, Inc. Sell -6.25% 4.98%
AGEN Agenus Inc. Sell -5.6% 16.67%
AVXL Anavex Life Sciences Corp. Sell -4.41% 10.8%
The percentage of cash held in the portfolio is: 88.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
DHR Buy All 16.83%
Assets Rebalanced
None
2023-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 17.43% 6.71%
CNC Centene Corporation Buy 17.3% 5.34%
AORT Artivion, Inc. Sell -6.74% -0.45%
BIO Bio-Rad Laboratories, Inc. Sell -6.33% 5.33%
DHR Danaher Corporation Sell -6.43% 3.79%
AGEN Agenus Inc. Sell -6.24% 8.73%
AVXL Anavex Life Sciences Corp. Sell -4.79% 4.63%
The percentage of cash held in the portfolio is: 95.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Sell All -18.33%
Assets Rebalanced
None
2023-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 17.23% 6.26%
CNC Centene Corporation Buy 17.31% 6.22%
IBRX ImmunityBio, Inc. Buy 7.15% -10.56%
AORT Artivion, Inc. Sell -6.55% 1.68%
BIO Bio-Rad Laboratories, Inc. Sell -6.33% 4.54%
DHR Danaher Corporation Sell -6.51% 1.93%
AGEN Agenus Inc. Sell -6.14% 9.52%
AVXL Anavex Life Sciences Corp. Sell -4.75% 4.77%
The percentage of cash held in the portfolio is: 88.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDXS Sell All -14.77%
Assets Rebalanced
None
2023-09-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 16.85% 4.1%
CNC Centene Corporation Buy 17.03% 4.67%
CDXS Codexis, Inc. Buy 14.87% -8.52%
IBRX ImmunityBio, Inc. Buy 7.25% -9.17%
AORT Artivion, Inc. Sell -6.48% 2.65%
BIO Bio-Rad Laboratories, Inc. Sell -6.4% 3.43%
DHR Danaher Corporation Sell -6.43% 2.86%
AGEN Agenus Inc. Sell -6.39% 5.56%
AVXL Anavex Life Sciences Corp. Sell -4.87% 2.24%
The percentage of cash held in the portfolio is: 74.57%
New Assets Added
None
Assets Removed
Asset Action Perf %
IOVA Sell All -15.01%
Assets Rebalanced
None
2023-09-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 16.5% 2.34%
CNC Centene Corporation Buy 16.61% 2.47%
CDXS Codexis, Inc. Buy 15.64% -3.41%
IBRX ImmunityBio, Inc. Buy 7.39% -6.94%
IOVA Iovance Biotherapeutics, Inc. Buy 11.48% -11.47%
AORT Artivion, Inc. Sell -6.41% 3.3%
BIO Bio-Rad Laboratories, Inc. Sell -6.5% 1.5%
DHR Danaher Corporation Sell -6.53% 0.98%
AGEN Agenus Inc. Sell -6.42% 4.76%
AVXL Anavex Life Sciences Corp. Sell -5.04% -1.54%
The percentage of cash held in the portfolio is: 63.27%
New Assets Added
None
Assets Removed
Asset Action Perf %
IMGN Sell All -8.1%
BHVN Sell All -12.29%
ICPT Sell All -8.77%
Assets Rebalanced
None
2023-09-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
IMGN ImmunoGen, Inc. Buy 10.46% -1.63%
HQY HealthEquity, Inc. Buy 16.01% 2.31%
CNC Centene Corporation Buy 16.07% 2.12%
BHVN Biohaven Ltd. Buy 14.62% -7.1%
CDXS Codexis, Inc. Buy 15.63% -0.57%
ICPT Intercept Pharmaceuticals, Inc. Buy 14.22% -6.75%
IBRX ImmunityBio, Inc. Buy 7.67% -0.56%
IOVA Iovance Biotherapeutics, Inc. Buy 11.53% -8.43%
AORT Artivion, Inc. Sell -6.28% 2.33%
BIO Bio-Rad Laboratories, Inc. Sell -6.24% 2.6%
DHR Danaher Corporation Sell -6.36% 0.68%
AGEN Agenus Inc. Sell -6.44% 1.59%
AVXL Anavex Life Sciences Corp. Sell -4.81% 0.14%
The percentage of cash held in the portfolio is: 23.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMEH Sell All -4.94%
STAA Sell All -7.33%
Assets Rebalanced
None
2023-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
IMGN ImmunoGen, Inc. Buy 10.37% -1.38%
HQY HealthEquity, Inc. Buy 15.13% -2.22%
CNC Centene Corporation Buy 15.89% 2.14%
BHVN Biohaven Ltd. Buy 14.62% -6.02%
STAA STAAR Surgical Company Buy 14.64% -5.83%
CDXS Codexis, Inc. Buy 15.99% 2.84%
ICPT Intercept Pharmaceuticals, Inc. Buy 14.4% -4.47%
AMEH Apollo Medical Holdings, Inc. Buy 7.43% -2.58%
IBRX ImmunityBio, Inc. Buy 7.08% -7.22%
IOVA Iovance Biotherapeutics, Inc. Buy 12.45% 0%
AORT Artivion, Inc. Sell -6.27% 1.42%
BIO Bio-Rad Laboratories, Inc. Sell -6.29% 0.61%
DHR Danaher Corporation Sell -6.25% 1.25%
AGEN Agenus Inc. Sell -6.42% 0.79%
AVXL Anavex Life Sciences Corp. Sell -4.76% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AVXL
  • IOVA
Assets Removed
None
Assets Rebalanced
None
2023-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IMGN ImmunoGen, Inc. Buy 10.06% -1.32%
HQY HealthEquity, Inc. Buy 14.94% -0.46%
CNC Centene Corporation Buy 15.4% 2.06%
BHVN Biohaven Ltd. Buy 14.81% -1.8%
STAA STAAR Surgical Company Buy 14.65% -2.8%
CDXS Codexis, Inc. Buy 16.61% 10.23%
ICPT Intercept Pharmaceuticals, Inc. Buy 14.11% -3.46%
AMEH Apollo Medical Holdings, Inc. Buy 7.4% 0%
IBRX ImmunityBio, Inc. Buy 7.4% 0%
AORT Artivion, Inc. Sell -5.91% 4.2%
BIO Bio-Rad Laboratories, Inc. Sell -6.24% -1.69%
DHR Danaher Corporation Sell -6.1% 0.68%
AGEN Agenus Inc. Sell -6.53% -3.97%
The percentage of cash held in the portfolio is: 9.4%
New Assets Added
  • AMEH
  • IBRX
Assets Removed
Asset Action Perf %
AMRX Buy All -11.08%
ATXS Sell All -9.49%
VERU Sell All -9.09%
DXCM Sell All -6.84%
Assets Rebalanced
None
2023-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 10.25% -2.51%
IMGN ImmunoGen, Inc. Buy 9.72% -3.01%
VERU Veru Inc. Buy 9.29% -7.27%
DXCM DexCom, Inc. Buy 10.16% 1.39%
HQY HealthEquity, Inc. Buy 15.01% 1.8%
CNC Centene Corporation Buy 14.95% 0.87%
BHVN Biohaven Ltd. Buy 14.64% -1.23%
STAA STAAR Surgical Company Buy 14.9% 0.65%
CDXS Codexis, Inc. Buy 14.72% -0.57%
ICPT Intercept Pharmaceuticals, Inc. Buy 14.36% 0%
AORT Artivion, Inc. Sell -5.99% 1.16%
BIO Bio-Rad Laboratories, Inc. Sell -5.9% 2.17%
AMRX Amneal Pharmaceuticals, Inc. Sell -6.52% -8.11%
DHR Danaher Corporation Sell -5.83% 3.37%
AGEN Agenus Inc. Sell -6.26% -1.59%
The percentage of cash held in the portfolio is: 2.51%
New Assets Added
  • ICPT
Assets Removed
None
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings